BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, Cannesson A, Cassuto-Viguier E, Thervet E, Conti F, Lebray P, Dalton HR, Santella R, Kanaan N, Essig M, Mousson C, Radenne S, Roque-Afonso AM, Izopet J, Rostaing L. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011;140:1481-9. [PMID: 21354150 DOI: 10.1053/j.gastro.2011.02.050] [Cited by in Crossref: 468] [Cited by in F6Publishing: 482] [Article Influence: 39.0] [Reference Citation Analysis]
Number Citing Articles
1 Henson JB, Muir AJ. Evaluation of an Abnormal Liver Panel After Liver Transplantation. Clin Liver Dis 2023;27:103-15. [PMID: 36400460 DOI: 10.1016/j.cld.2022.08.006] [Reference Citation Analysis]
2 Cancela F, Rendon-Marin S, Quintero-Gil C, Houston DR, Gumbis G, Panzera Y, Pérez R, Arbiza J, Mirazo S. Modelling of Hepatitis E virus RNA-dependent RNA polymerase genotype 3 from a chronic patient and in silico interaction analysis by molecular docking with Ribavirin. J Biomol Struct Dyn 2023;41:705-21. [PMID: 34861797 DOI: 10.1080/07391102.2021.2011416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kupke P, Adenugba A, Schemmerer M, Bitterer F, Schlitt HJ, Geissler EK, Wenzel JJ, Werner JM. Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection. Cells 2023;12:453. [DOI: 10.3390/cells12030453] [Reference Citation Analysis]
4 Abravanel F, Lhomme S, Marion O, Péron JM, Kamar N, Izopet J. Diagnostic and management strategies for chronic hepatitis E infection. Expert Rev Anti Infect Ther 2023;:1-6. [PMID: 36625025 DOI: 10.1080/14787210.2023.2166932] [Reference Citation Analysis]
5 Biedermann P, Klink P, Nocke MK, Papp CP, Harms D, Kebelmann M, Thürmer A, Choi M, Altmann B, Todt D, Hofmann J, Bock CT. Insertions and deletions in the hypervariable region of the hepatitis E virus genome in individuals with acute and chronic infection. Liver Int 2023. [PMID: 36617681 DOI: 10.1111/liv.15517] [Reference Citation Analysis]
6 Wadhawan M, Argal S. Viral Markers and Their Relevance in Liver Disease and Transplantation. Peri-operative Anesthetic Management in Liver Transplantation 2023. [DOI: 10.1007/978-981-19-6045-1_6] [Reference Citation Analysis]
7 Peeters M, Schenk J, De Somer T, Roskams T, Locus T, Klamer S, Subissi L, Suin V, Delwaide J, Stärkel P, De Maeght S, Willems P, Colle I, Van Hoof M, Van Acker J, Van Steenkiste C, Moreno C, Janssens F, Reynders M, Steverlynck M, Verlinden W, Lasser L, de Galocsy C, Geerts A, Maus J, Gallant M, Van Outryve S, Marot A, Reynaert H, Decaestecker J, Bottieau E, Schreiber J, Mulkay JP, de Goeij S, Salame M, Dooremont D, Dastis SN, Boes J, Nijs J, Beyls J, Hens N, Nevens F, Van Gucht S, Vanwolleghem T; Belgian Association for the Study of the Liver. Viral clade is associated with severity of symptomatic genotype 3 hepatitis E virus infections in Belgium, 2010-2018. J Hepatol 2023;78:67-77. [PMID: 36075495 DOI: 10.1016/j.jhep.2022.08.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bauer DJM, Aberle S, Farthofer A, Chromy D, Simbrunner B, Mandorfer M, Schmidt R, Trauner M, Strassl R, Mayer F, Holzmann H, Reiberger T. Low mortality despite temporary liver dysfunction in severe courses of acute hepatitis E. Wien Klin Wochenschr 2022. [DOI: 10.1007/s00508-022-02126-8] [Reference Citation Analysis]
9 Samala N, Wang RY, Auh S, Balla AK, Dakhoul L, Alter HJ, Farci P, Ghabril M, Lucey MR, Rangnekar AS, Reddy KR, Ghany MG. Hepatitis E prevalence and infection in solid-organ transplant recipients in the United States. J Viral Hepat 2022;29:1134-42. [PMID: 36036116 DOI: 10.1111/jvh.13739] [Reference Citation Analysis]
10 Dammermann W, von Menges A, Singethan K, Pischke S, Ritter O, Lüth S, Ullrich S. Increased Seroprevalence of Campylobacter jejuni, but not HEV, in healthcare workers in gastroenterological endoscopy. Z Gastroenterol 2022;60:1763-9. [PMID: 35697063 DOI: 10.1055/a-1833-8917] [Reference Citation Analysis]
11 Takakusagi S, Takagi H, Yamazaki Y, Kosone T, Nagashima S, Takahashi M, Murata K, Okamoto H. Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment. Clin J Gastroenterol 2022. [DOI: 10.1007/s12328-022-01733-2] [Reference Citation Analysis]
12 Frankal M, Skoglund C, Castedal M, Lagging M, Norder H. Hepatitis E Virus Infection, a Risk for Liver Transplant Recipients in Sweden. Transplantation Direct 2022;8:e1409. [DOI: 10.1097/txd.0000000000001409] [Reference Citation Analysis]
13 Yen DW, Sherman KE. Causes and outcomes of hepatic fibrosis in persons living with HIV. Curr Opin HIV AIDS 2022;17:359-67. [PMID: 36165079 DOI: 10.1097/COH.0000000000000760] [Reference Citation Analysis]
14 Sequeira C, Coelho M, Costa Santos I, Ramos Lopes S, Mangualde J, Oliveira AP. Severe Hypercholesterolemia Mediated by Lipoprotein X in an Immunosuppressed Patient: A Case Report. GE Port J Gastroenterol 2022. [DOI: 10.1159/000526854] [Reference Citation Analysis]
15 Jelicic P, Ferenc T, Mrzljak A, Jemersic L, Janev-Holcer N, Milosevic M, Bogdanic M, Barbic L, Kolaric B, Stevanovic V, Vujica M, Jurekovic Z, Pavicic Saric J, Vilibic M, Vilibic-Cavlek T. Insights into hepatitis E virus epidemiology in Croatia. World J Gastroenterol 2022; 28(37): 5494-5505 [DOI: 10.3748/wjg.v28.i37.5494] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chen Z, Wei J, Jiang L, Ying D, Tian W, Zhang M, Wen G, Wang S, Liu C, Wang Y, Wu T, Tang Z, Zheng Z, Yan L, Xia N. Case Report: Chronic hepatitis E in a hematopoietic stem cell transplant recipient: The first report of hepatitis E virus genotype 4 causing chronic infection in a non-solid organ recipient. Front Immunol 2022;13:954697. [DOI: 10.3389/fimmu.2022.954697] [Reference Citation Analysis]
17 Ma Z, de Man RA, Kamar N, Pan Q. Chronic hepatitis E: Advancing research and patient care. J Hepatol 2022;77:1109-23. [PMID: 35605741 DOI: 10.1016/j.jhep.2022.05.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Sridhar S, Wu S, Situ J, Shun EH, Li Z, Zhang AJ, Hui K, Fong CH, Poon VK, Chew NF, Yip CC, Chan WM, Cai JP, Yuen KY. A small animal model of chronic hepatitis E infection using immunocompromised rats. JHEP Rep 2022;4:100546. [PMID: 36052220 DOI: 10.1016/j.jhepr.2022.100546] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Kamar N, Del Bello A, Abravanel F, Pan Q, Izopet J. Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients. Viruses 2022;14:2116. [DOI: 10.3390/v14102116] [Reference Citation Analysis]
20 He Q, Zhang F, Shu J, Li S, Liang Z, Du M, Liu X, Liu T, Li M, Yin X, Pan Q, Lu F, Wang L, Wang L. Immunocompromised rabbit model of chronic HEV reveals liver fibrosis and distinct efficacy of different vaccination strategies. Hepatology 2022;76:788-802. [PMID: 35278241 DOI: 10.1002/hep.32455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Markakis GE, Papatheodoridis GV, Cholongitas E. Epidemiology and treatment of hepatitis E in the liver transplantation setting: A literature review. J Viral Hepat 2022;29:698-718. [PMID: 35644040 DOI: 10.1111/jvh.13709] [Reference Citation Analysis]
22 Vij M, Rammohan A, Rela M. Long-term liver allograft fibrosis: A review with emphasis on idiopathic post-transplant hepatitis and chronic antibody mediated rejection. World J Hepatol 2022; 14(8): 1541-1549 [DOI: 10.4254/wjh.v14.i8.1541] [Reference Citation Analysis]
23 Carter M, Solsrud K, Yeddula S, Fitzmaurice MG, Singh A, Nagai S, Jafri SM. Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single-Center Experience. Transplant Proc 2022:S0041-1345(22)00438-9. [PMID: 35907694 DOI: 10.1016/j.transproceed.2022.04.025] [Reference Citation Analysis]
24 Meester M, Bouwknegt M, Hakze-van der Honing R, Vernooij H, Houben M, van Oort S, van der Poel WHM, Stegeman A, Tobias T. Repeated cross-sectional sampling of pigs at slaughter indicates varying age of hepatitis E virus infection within and between pig farms. Vet Res 2022;53:50. [PMID: 35799280 DOI: 10.1186/s13567-022-01068-3] [Reference Citation Analysis]
25 Boukhrissa H, Mechakra S, Mahnane A, Boussouf N, Gasmi A, Lacheheb A. Seroprevalence of hepatitis E virus among blood donors in eastern Algeria. Trop Doct 2022;:494755221112212. [PMID: 35791644 DOI: 10.1177/00494755221112212] [Reference Citation Analysis]
26 Correia AL, Pimenta AC, Carias E, Guedes Marques M, Leal R, Rodrigues L, Santos L, Romãozinho C, Leitão J, Alves R, Figueiredo A. A Less Common Cause of Acute Hepatitis in Kidney Transplant Recipients: A Case Series. Transplant Proc 2022:S0041-1345(22)00319-0. [PMID: 35768296 DOI: 10.1016/j.transproceed.2022.03.037] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Liang C, Zhao C, Liu T, Liu B, Liu Z, Huang H, Liu W, Zhao M, Xu N, Lu Q, Nie J, Zhang L, Huang W, She R, Wang Y. Characterization of Chronic Hepatitis E Virus Infection in Immunocompetent Rabbits. Viruses 2022;14:1252. [PMID: 35746723 DOI: 10.3390/v14061252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Fernández Villalobos NV, Kessel B, Rodiah I, Ott JJ, Lange B, Krause G. Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis. PLoS ONE 2022;17:e0269253. [DOI: 10.1371/journal.pone.0269253] [Reference Citation Analysis]
29 Ibrahim YM, Werid GM, Zhang H, Fu L, Wang W, Chen H, Wang Y. Potential Zoonotic Swine Enteric Viruses: The Risk Ignored for Public Health. Virus Res 2022;:198767. [PMID: 35421434 DOI: 10.1016/j.virusres.2022.198767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Nagra N, Kozarek RA, Burman BE. Therapeutic Advances in Viral Hepatitis A-E. Adv Ther 2022;39:1524-52. [PMID: 35220557 DOI: 10.1007/s12325-022-02070-z] [Reference Citation Analysis]
31 Damiris K, Aghaie Meybodi M, Niazi M, Pyrsopoulos N. Hepatitis E in immunocompromised individuals. World J Hepatol 2022; 14(3): 482-494 [DOI: 10.4254/wjh.v14.i3.482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Fang L, Zhang J, Chen H, Lv F, Yu Y, Du X. Epidemiological Characteristics and Clinical Manifestations of Hepatitis E in a Tertiary Hospital in China: A Retrospective Study. Front Microbiol 2021;12:831968. [PMID: 35310389 DOI: 10.3389/fmicb.2021.831968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Weis-torres SMDS, França ADO, Granato C, Passarini A, Motta-castro ARC. Seroprevalence of hepatitis E virus infection among volunteer blood donors in Central Brazil. The Brazilian Journal of Infectious Diseases 2022;26:102350. [DOI: 10.1016/j.bjid.2022.102350] [Reference Citation Analysis]
34 El-kafrawy SA, El-daly MM. Hepatitis E virus in Saudi Arabia: more surveillance needed. Future Virology. [DOI: 10.2217/fvl-2021-0320] [Reference Citation Analysis]
35 Cheung CKM, Wong SH, Law AWH, Law MF. Transfusion-transmitted hepatitis E: What we know so far? World J Gastroenterol 2022;28:47-75. [PMID: 35125819 DOI: 10.3748/wjg.v28.i1.47] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
36 Dunn R, Wetten A, McPherson S, Donnelly MC. Viral hepatitis in 2021: The challenges remaining and how we should tackle them. World J Gastroenterol 2022; 28(1): 76-95 [DOI: 10.3748/wjg.v28.i1.76] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
37 Mescoli C, Albertoni L, Demetris AJ. Role of Histopathology in Liver Dysfunction After Transplant. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_18] [Reference Citation Analysis]
38 Lampejo T. Sofosbuvir in the Treatment of Hepatitis E virus Infection: A Review of in vitro and in vivo Evidence. J Clin Exp Hepatol 2022;12:1225-37. [PMID: 35814503 DOI: 10.1016/j.jceh.2022.02.003] [Reference Citation Analysis]
39 Raji YE, Toung OP, Taib NM, Sekawi ZB. Hepatitis E Virus: An emerging enigmatic and underestimated pathogen. Saudi J Biol Sci 2022;29:499-512. [PMID: 35002446 DOI: 10.1016/j.sjbs.2021.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
40 . Transplantation Pathology. Non-Neoplastic Diseases of the Liver 2022. [DOI: 10.55418/9781933477183-11] [Reference Citation Analysis]
41 . Viral Hepatitis. Non-Neoplastic Diseases of the Liver 2022. [DOI: 10.55418/9781933477183-2] [Reference Citation Analysis]
42 González Grande R, Santaella Leiva I, López Ortega S, Jiménez Pérez M. Present and future management of viral hepatitis. World J Gastroenterol 2021; 27(47): 8081-8102 [DOI: 10.3748/wjg.v27.i47.8081] [Reference Citation Analysis]
43 Trongtorsak A, Chaisidhivej N, Yadav K, Kim J, Thongprayoon C, Cheungpasitporn W, Hansrivijit P. Hepatitis E virus infection in hematopoietic stem cell transplant recipients: a systematic review and meta-analysis. J Investig Med 2021:jim-2021-002102. [PMID: 34930797 DOI: 10.1136/jim-2021-002102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Wasuwanich P, Sirisreetreerux P, Ingviya T, Kraus ES, Brennan DC, Sue PK, Jackson AM, Oshima K, Philosophe B, Montgomery RA, Karnsakul W. Hepatitis E virus infection and rejection in kidney transplant recipients. Transpl Immunol 2021;70:101517. [PMID: 34923120 DOI: 10.1016/j.trim.2021.101517] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Klöhn M, Schrader JA, Brüggemann Y, Todt D, Steinmann E. Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:5867. [PMID: 34831021 DOI: 10.3390/cancers13225867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
46 Mikulska M, Penack O, Wendel L, Knelange N, Cornelissen JJ, Blijlevens N, Passweg J, Kroger N, Bruns A, Koenecke C, Bierings M, Piñana JL, Labussiere-Wallet H, Ghesquieres H, Diaz MA, Sampol A, Averbuch D, de la Camara R, Styczynski J. HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working Party. Bone Marrow Transplant 2021. [PMID: 34689177 DOI: 10.1038/s41409-021-01497-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Belei O, Ancusa O, Mara A, Olariu L, Amaricai E, Folescu R, Zamfir CL, Gurgus D, Motoc AG, Stânga LC, Strat L, Marginean O. Current Paradigm of Hepatitis E Virus Among Pediatric and Adult Patients. Front Pediatr 2021;9:721918. [PMID: 34660485 DOI: 10.3389/fped.2021.721918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Yadav KK, Kenney SP. Hepatitis E Virus Immunopathogenesis. Pathogens 2021;10:1180. [PMID: 34578211 DOI: 10.3390/pathogens10091180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Kupke P, Werner JM. Hepatitis E Virus Infection-Immune Responses to an Underestimated Global Threat. Cells 2021;10:2281. [PMID: 34571931 DOI: 10.3390/cells10092281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Yao L, Nisar MF, Yan T, Wan C(, Cai S. Potential Effects of Dietary Isoflavones on Drug-Induced Liver Injury. Journal of Food Quality 2021;2021:1-10. [DOI: 10.1155/2021/2870969] [Reference Citation Analysis]
51 Torre P, Aglitti A, Masarone M, Persico M. Viral hepatitis: Milestones, unresolved issues, and future goals. World J Gastroenterol 2021; 27(28): 4603-4638 [PMID: 34366625 DOI: 10.3748/wjg.v27.i28.4603] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
52 Fu P, Lin B, Wu B, Ke L, Yang T, Du Y, Cheng L, Li Z, Li T, Liu Y. Hepatitis E virus prevalence among blood donors in Dali, China. Virol J 2021;18:141. [PMID: 34233712 DOI: 10.1186/s12985-021-01607-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Velavan TP, Pallerla SR, Johne R, Todt D, Steinmann E, Schemmerer M, Wenzel JJ, Hofmann J, Shih JWK, Wedemeyer H, Bock CT. Hepatitis E: An update on One Health and clinical medicine. Liver Int 2021;41:1462-73. [PMID: 33960603 DOI: 10.1111/liv.14912] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
54 Sherman KE, Kottilil S, Rouster SD, Abdel-Hameed EA, Boyce CL, Meeds HL, Terrault N, Shata MT. Hepatitis E Infection in a Longitudinal Cohort of Hepatitis C Virus and HCV/HIV Coinfected Persons. AIDS Res Hum Retroviruses 2021;37:534-41. [PMID: 33794657 DOI: 10.1089/AID.2020.0303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Zhang W, Aryan M, Qian S, Cabrera R, Liu X. A Focused Review on Recent Advances in the Diagnosis and Treatment of Viral Hepatitis. Gastroenterology Res 2021;14:139-56. [PMID: 34267829 DOI: 10.14740/gr1405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Mrzljak A, Jemersic L, Savic V, Balen I, Ilic M, Jurekovic Z, Pavicic-Saric J, Mikulic D, Vilibic-Cavlek T. Hepatitis E Virus in Croatia in the "One-Health" Context. Pathogens 2021;10:699. [PMID: 34199798 DOI: 10.3390/pathogens10060699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
57 Maslennikov R, Ivashkin V, Efremova I, Shirokova E. Immune disorders and rheumatologic manifestations of viral hepatitis. World J Gastroenterol 2021;27:2073-89. [PMID: 34025065 DOI: 10.3748/wjg.v27.i18.2073] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
58 Castaneda D, Gonzalez AJ, Alomari M, Tandon K, Zervos XB. From hepatitis A to E: A critical review of viral hepatitis. World J Gastroenterol 2021; 27(16): 1691-1715 [PMID: 33967551 DOI: 10.3748/wjg.v27.i16.1691] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
59 Kamar N, Abravanel F, Behrendt P, Hofmann J, Pageaux GP, Barbet C, Moal V, Couzi L, Horvatits T, De Man RA, Cassuto E, Elsharkawy AM, Riezebos-Brilman A, Scemla A, Hillaire S, Donnelly MC, Radenne S, Sayegh J, Garrouste C, Dumortier J, Glowaki F, Matignon M, Coilly A, Figueres L, Mousson C, Minello A, Dharancy S, Rerolle JP, Lebray P, Etienne I, Perrin P, Choi M, Marion O, Izopet J;  Hepatitis E Virus Ribavirin Study Group. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study. Clin Infect Dis. 2020;71:1204-1211. [PMID: 31793638 DOI: 10.1093/cid/ciz953] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
60 Grigas J, Montoya M, Simkute E, Buitkus M, Zagrabskaite R, Pautienius A, Razukevicius D, Jonaitis LV, Kiudelis G, Skieceviciene J, Vaiciuniene R, Stankuviene A, Bumblyte IA, Kupcinskas J, Stankevicius A. Molecular Characterization and Seroprevalence of Hepatitis E Virus in Inflammatory Bowel Disease Patients and Solid Organ Transplant Recipients. Viruses 2021;13:670. [PMID: 33924409 DOI: 10.3390/v13040670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Gao E, Hercun J, Heller T, Vilarinho S. Undiagnosed liver diseases. Transl Gastroenterol Hepatol 2021;6:28. [PMID: 33824932 DOI: 10.21037/tgh.2020.04.04] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
62 Smith SK, Rosenthal P. Hepatitis A and Hepatitis E Virus in Children. Liver Disease in Children 2021. [DOI: 10.1017/9781108918978.017] [Reference Citation Analysis]
63 Pellerin M, Hirchaud E, Blanchard Y, Pavio N, Doceul V. Characterization of a Cell Culture System of Persistent Hepatitis E Virus Infection in the Human HepaRG Hepatic Cell Line. Viruses 2021;13:406. [PMID: 33806591 DOI: 10.3390/v13030406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Gorris M, van der Lecq BM, van Erpecum KJ, de Bruijne J. Treatment for chronic hepatitis E virus infection: A systematic review and meta-analysis. J Viral Hepat 2021;28:454-63. [PMID: 33301609 DOI: 10.1111/jvh.13456] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
65 Buescher G, Ozga AK, Lorenz E, Pischke S, May J, Addo MM, Horvatits T. Hepatitis E seroprevalence and viremia rate in immunocompromised patients: a systematic review and meta-analysis. Liver Int 2021;41:449-55. [PMID: 33034121 DOI: 10.1111/liv.14695] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
66 Minosse C, Lapa D, Coppola A, Rapagna F, D'Offizi G, Taibi C, Lionetti R, Capobianchi MR, McPhee F, Garbuglia AR. Anti-HEV IgG Avidity Testing: Utility for Diagnosing Acute and Resolved Genotype 3 Infections. Viruses 2021;13:236. [PMID: 33546482 DOI: 10.3390/v13020236] [Reference Citation Analysis]
67 Ankcorn M, Said B, Morgan D, Elsharkawy AM, Maggs J, Ryder S, Valliani T, Gordon F, Abeysekera K, Suri D, McPherson S, Galliford J, Smith B, Pelosi E, Bansal S, Bethune C, Sheridan D, Vine L, Tedder RS, Ijaz S; enhanced persistent HEV surveillance group. Persistent Hepatitis E virus infection across England and Wales 2009-2017: Demography, virology and outcomes. J Viral Hepat 2021;28:420-30. [PMID: 33073452 DOI: 10.1111/jvh.13424] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
68 Balaban HY, Aslan AT, Akdoğan Kittana FN, Alp A, Dağ O, Ayar ŞN, Vahabov C, Şimşek C, Yıldırım T, Göker H, Ergünay K, Erdem Y, Büyükaşık Y, Şimşek H. Hepatitis E virus seroprevalence and associated risk factors in high-risk groups: A cross-sectional study from Turkey.. [DOI: 10.1101/2021.01.25.21250429] [Reference Citation Analysis]
69 Lu J, Huang Y, Wang P, Li Q, Li Z, Jiang J, Guo Q, Gui H, Xie Q. Dynamics of Hepatitis E Virus (HEV) Antibodies and Development of a Multifactorial Model To Improve the Diagnosis of HEV Infection in Resource-Limited Settings. J Clin Microbiol 2021;59:e02321-20. [PMID: 33239375 DOI: 10.1128/JCM.02321-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
70 Hartleif S, Sturm E. Chronic Graft Injury. Pediatric Liver Transplantation 2021. [DOI: 10.1016/b978-0-323-63671-1.00044-6] [Reference Citation Analysis]
71 Debray D. Immunological and Other Late Complications. Pediatric Liver Transplantation 2021. [DOI: 10.1016/b978-0-323-63671-1.00027-6] [Reference Citation Analysis]
72 Rathi S, Duseja A, Thakur V, Ratho RK, Singh MP, Taneja S, Das A, Aggarwal R, Dhiman RK, Chawla YK. Chronic Hepatitis E With Genotype 1-Masquerading as Allograft Rejection After LiverTransplantation. J Clin Exp Hepatol 2021;11:400-3. [PMID: 33994721 DOI: 10.1016/j.jceh.2020.07.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
73 Marion O, Kamar N. Hepatitis E Infections in Transplants. Emerging Transplant Infections 2021. [DOI: 10.1007/978-3-030-25869-6_36] [Reference Citation Analysis]
74 Fawaz R, Jonas MM. Acute and Chronic Hepatitis. Pediatric Gastrointestinal and Liver Disease 2021. [DOI: 10.1016/b978-0-323-67293-1.00075-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Hammig J, Wedemeyer H. Hepatitis-A- und -E-Virus-Infektionen – Altes und Neues. Krankenhaushygiene up2date 2020;15:375-389. [DOI: 10.1055/a-1266-2003] [Reference Citation Analysis]
76 van den Bogaart L, Cipriano A, Koutsokera A, Manuel O. Understanding rare infections post-lung transplantation. Expert Rev Respir Med 2021;15:325-38. [PMID: 33106068 DOI: 10.1080/17476348.2021.1843428] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Aslan AT, Balaban HY. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment. World J Gastroenterol 2020; 26(37): 5543-5560 [PMID: 33071523 DOI: 10.3748/wjg.v26.i37.5543] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 36] [Article Influence: 12.7] [Reference Citation Analysis]
78 Hoffmann P, Behnisch R, Gsenger J, Schnitzler P, Gauss A. Hepatitis E seroprevalence in a German cohort of patients with inflammatory bowel diseases. PLoS One 2020;15:e0239825. [PMID: 33027305 DOI: 10.1371/journal.pone.0239825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
79 Kemmner S, Schönermarck U. Infektionen unter Immunsuppression nach Nierentransplantation. Dialyse aktuell 2020;24:309-318. [DOI: 10.1055/a-1176-6416] [Reference Citation Analysis]
80 Thakur V, Ratho RK, Kumar S, Saxena SK, Bora I, Thakur P. Viral Hepatitis E and Chronicity: A Growing Public Health Concern. Front Microbiol 2020;11:577339. [PMID: 33133046 DOI: 10.3389/fmicb.2020.577339] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
81 Nasir M, Wu GY. HEV and HBV Dual Infection: A Review. J Clin Transl Hepatol 2020;8:313-21. [PMID: 33083255 DOI: 10.14218/JCTH.2020.00030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
82 Di Bartolomeo S, Carubbi F, Cipriani P. Hepatitis E Virus and rheumatic diseases: what do rheumatologists need to know? BMC Rheumatol 2020;4:51. [PMID: 32974609 DOI: 10.1186/s41927-020-00149-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
83 Crum-Cianflone NF. Therapy for Chronic Hepatitis E Virus Infection-Current Recommendations and Future Aspirations. Clin Infect Dis 2020;71:1212-4. [PMID: 31793631 DOI: 10.1093/cid/ciz955] [Reference Citation Analysis]
84 Cheung A, Kwo P. Viral Hepatitis Other than A, B, and C: Evaluation and Management. Clin Liver Dis 2020;24:405-19. [PMID: 32620280 DOI: 10.1016/j.cld.2020.04.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
85 Perisetti A, Laoveeravat P, Inamdar S, Tharian B, Thandassery R, Goyal H. Hepatitis E virus infection in liver transplant recipients: a descriptive literature review. Eur J Gastroenterol Hepatol 2020;32:916-22. [PMID: 32091436 DOI: 10.1097/MEG.0000000000001682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
86 Kar P, Karna R. A Review of the Diagnosis and Management of Hepatitis E. Curr Treat Options Infect Dis 2020;:1-11. [PMID: 32837339 DOI: 10.1007/s40506-020-00235-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
87 Salines M, Andraud M, Rose N, Widgren S. A between-herd data-driven stochastic model to explore the spatio-temporal spread of hepatitis E virus in the French pig production network. PLoS One 2020;15:e0230257. [PMID: 32658910 DOI: 10.1371/journal.pone.0230257] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
88 Thodou V, Bremer B, Anastasiou OE, Cornberg M, Maasoumy B, Wedemeyer H. Performance of Roche qualitative HEV assay on the cobas 6800 platform for quantitative measurement of HEV RNA. J Clin Virol 2020;129:104525. [PMID: 32623349 DOI: 10.1016/j.jcv.2020.104525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
89 Tanaka A, Hoshi Y, Hasegawa T, Sakata H, Furui Y, Goto N, Taira R, Matsubayashi K, Satake M. THE CURRENT STATUS OF TRANSFUSION-TRANSMITTED HEPATITIS E VIRUS INFECTION IN JAPAN. JJTC 2020;66:531-7. [DOI: 10.3925/jjtc.66.531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
90 Lenggenhager D, Pawel S, Honcharova-Biletska H, Evert K, Wenzel JJ, Montani M, Furrer E, Fraga M, Moradpour D, Sempoux C, Weber A. The histologic presentation of hepatitis E reflects patients' immune status and pre-existing liver condition. Mod Pathol 2021;34:233-48. [PMID: 32572157 DOI: 10.1038/s41379-020-0593-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
91 Forgan-Smith KR, Macdonald G. Chronic hepatitis E infection in an immunosuppressed, solid organ transplant patient. Intern Med J 2019;49:1335-6. [PMID: 31602774 DOI: 10.1111/imj.14458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
92 Luxenburger H, Thimme R, Bettinger D. Die Hepatitis-E-Virus-Infektion. Gastroenterologe 2020;15:186-193. [DOI: 10.1007/s11377-020-00441-y] [Reference Citation Analysis]
93 Whitsett M, Feldman DM, Jacobson I. Hepatitis E Virus Infection in the United States: Current Understanding of the Prevalence and Significance in the Liver Transplant Patient Population and Proposed Diagnostic and Treatment Strategies. Liver Transpl 2020;26:709-17. [PMID: 32061053 DOI: 10.1002/lt.25732] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
94 Janahi EM, Parkar SFD, Mustafa S, Eisa ZM. Implications of Hepatitis E Virus in Blood Transfusions, Hemodialysis, and Solid Organ Transplants. Medicina (Kaunas) 2020;56:E206. [PMID: 32344807 DOI: 10.3390/medicina56050206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
95 Sooryanarain H, Meng XJ. Swine hepatitis E virus: Cross-species infection, pork safety and chronic infection. Virus Res 2020;284:197985. [PMID: 32333941 DOI: 10.1016/j.virusres.2020.197985] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
96 Webb GW, Dalton HR. Hepatitis E: an expanding epidemic with a range of complications. Clin Microbiol Infect 2020;26:828-32. [PMID: 32251845 DOI: 10.1016/j.cmi.2020.03.039] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
97 Abi Nader E, Girard M, Leruez-Ville M, Sissaoui S, Lacaille F, Roque-Afonso AM, Debray D. Seroprevalence of Hepatitis E virus infection in children after liver transplantation: A single-center experience in France. Clin Res Hepatol Gastroenterol 2020;44:174-80. [PMID: 31266724 DOI: 10.1016/j.clinre.2019.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
98 Mrzljak A, Novak R, Pandak N, Tabain I, Franusic L, Barbic L, Bogdanic M, Savic V, Mikulic D, Pavicic-Saric J, Stevanovic V, Vilibic-Cavlek T. Emerging and neglected zoonoses in transplant population. World J Transplant 2020; 10(3): 47-63 [PMID: 32257849 DOI: 10.5500/wjt.v10.i3.47] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
99 Kamar N, Izopet J. Chronic hepatitis E virus infection: is it reality or hype and where does it matter? Clinical Dilemmas in Viral Liver Disease 2020. [DOI: 10.1002/9781119533481.ch33] [Reference Citation Analysis]
100 Navarro A, Bárcena C, Pozo P, Díez-Guerrier A, Martínez I, Polo C, Duque C, Rodríguez-Lázaro D, Goyache J, García N. Liver Transudate, a Potential Alternative to Detect Anti-Hepatitis E Virus Antibodies in Pigs and Wild Boars (Sus scrofa). Microorganisms 2020;8:E450. [PMID: 32210090 DOI: 10.3390/microorganisms8030450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
101 Furfaro E, Nicolini L, Della Vecchia A, Di Grazia C, Raiola AM, Varaldo R, Ferrando F, Barisione G, Bruzzone B, Angelucci E, Viscoli C, Mikulska M. Hepatitis E Virus Infection in an Italian Cohort of Hematopoietic Stem Cell Transplantation Recipients: Seroprevalence and Infection. Biol Blood Marrow Transplant 2020;26:1355-62. [PMID: 32200124 DOI: 10.1016/j.bbmt.2020.03.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
102 Darstein F, Häuser F, Mittler J, Zimmermann A, Lautem A, Hoppe-Lotichius M, Otto G, Lang H, Galle PR, Zimmermann T. Hepatitis E Is a Rare Finding in Liver Transplant Patients With Chronic Elevated Liver Enzymes and Biopsy-Proven Acute Rejection. Transplant Proc 2020;52:926-31. [PMID: 32139278 DOI: 10.1016/j.transproceed.2020.01.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
103 Seth A, Sherman KE. Hepatitis E: What We Think We Know. Clin Liver Dis (Hoboken). 2020;15:S37-S44. [PMID: 32140212 DOI: 10.1002/cld.858] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
104 Pankovics P, Némethy O, Boros Á, Pár G, Szakály P, Reuter G. Four-year long (2014-2017) clinical and laboratory surveillance of hepatitis E virus infections using combined antibody, molecular, antigen and avidity detection methods: Increasing incidence and chronic HEV case in Hungary. Journal of Clinical Virology 2020;124:104284. [DOI: 10.1016/j.jcv.2020.104284] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
105 Meng X. Hepatitis E Virus. The Liver 2020. [DOI: 10.1002/9781119436812.ch68] [Reference Citation Analysis]
106 Istrate A, Rădulescu AL. A comparison of hepatitis E and A in a teaching hospital in Northwestern Romania. Acute hepatitis E - a mild disease? Med Pharm Rep 2020;93:30-8. [PMID: 32133444 DOI: 10.15386/mpr-1487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
107 Lhomme S, Marion O, Abravanel F, Izopet J, Kamar N. Clinical Manifestations, Pathogenesis and Treatment of Hepatitis E Virus Infections. J Clin Med. 2020;9. [PMID: 31991629 DOI: 10.3390/jcm9020331] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 13.7] [Reference Citation Analysis]
108 Da BL, Nguyen A, Khan A, Dieterich DT. Viral Hepatitis Non: B, C, D and Acute and Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_10] [Reference Citation Analysis]
109 Jothimani D, Venugopal R, Vij M, Rela M. Post liver transplant recurrent and de novo viral infections. Best Pract Res Clin Gastroenterol 2020;46-47:101689. [PMID: 33158469 DOI: 10.1016/j.bpg.2020.101689] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
110 王 文. Regulation of NF-Kappa B Signaling Pathway by Hepatitis Viruses. HJBM 2020;10:35-42. [DOI: 10.12677/hjbm.2020.103006] [Reference Citation Analysis]
111 Marion O, Kamar N. Hepatitis E Infections in Transplants. Emerging Transplant Infections 2020. [DOI: 10.1007/978-3-030-01751-4_36-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Mrzljak A, Dinjar-Kujundzic P, Knotek M, Kudumija B, Ilic M, Gulin M, Zibar L, Hrstic I, Jurekovic Z, Kolaric B, Jemersic L, Prpic J, Tomljenovic M, Vilibic-Cavlek T. Seroepidemiology of hepatitis E in patients on haemodialysis in Croatia. Int Urol Nephrol 2020;52:371-8. [PMID: 31894559 DOI: 10.1007/s11255-019-02363-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
113 Li Y, Huang J, Jia J. Hepatitis E. Liver Immunology 2020. [DOI: 10.1007/978-3-030-51709-0_19] [Reference Citation Analysis]
114 Ustianowski A, Devine K. Viral hepatitis. Handbook of Systemic Autoimmune Diseases 2020. [DOI: 10.1016/b978-0-444-64217-2.00004-x] [Reference Citation Analysis]
115 Rossotti R, Puoti M. Sexually Transmitted Hepatitis. Sexually Transmitted Infections 2020. [DOI: 10.1007/978-3-030-02200-6_13] [Reference Citation Analysis]
116 Rivero-Juarez A, Vallejo N, Lopez-Lopez P, Díaz-Mareque AI, Frias M, Vallejo A, Caballero-Gómez J, Rodríguez-Velasco M, Molina E, Aguilera A. Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients. Microorganisms 2019;8:E51. [PMID: 31888090 DOI: 10.3390/microorganisms8010051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
117 Teixeira-Costa C, Andraud M, Rose N, Salines M. Controlling hepatitis E virus in the pig production sector: Assessment of the technical and behavioural feasibility of on-farm risk mitigation strategies. Prev Vet Med. 2020;175:104866. [PMID: 31838401 DOI: 10.1016/j.prevetmed.2019.104866] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
118 Mrzljak A, Tabain I, Premac H, Bogdanic M, Barbic L, Savic V, Stevanovic V, Jelic A, Mikulic D, Vilibic-Cavlek T. The Role of Emerging and Neglected Viruses in the Etiology of Hepatitis. Curr Infect Dis Rep 2019;21:51. [PMID: 31754812 DOI: 10.1007/s11908-019-0709-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
119 Harritshøj LH, Hother CE, Sengeløv H, Daugaard G, Sørensen SS, Jacobsen S, Perch M, Holm DK, Sækmose SG, Aagaard B, Erikstrup C, Hogema BM, Lundgren JD, Ullum H. Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patients. Int J Infect Dis 2020;91:188-95. [PMID: 31756566 DOI: 10.1016/j.ijid.2019.11.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
120 Ankcorn MJ, Tedder RS, Cairns J, Sandmann FG. Cost-Effectiveness Analysis of Screening for Persistent Hepatitis E Virus Infection in Solid Organ Transplant Patients in the United Kingdom: A Model-Based Economic Evaluation. Value Health. 2020;23:309-318. [PMID: 32197726 DOI: 10.1016/j.jval.2019.09.2751] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
121 Agrawal B. Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections. Front Immunol 2019;10:2631. [PMID: 31781118 DOI: 10.3389/fimmu.2019.02631] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 11.8] [Reference Citation Analysis]
122 Chauhan A, Webb G, Ferguson J. Clinical presentations of Hepatitis E: A clinical review with representative case histories. Clin Res Hepatol Gastroenterol 2019;43:649-57. [PMID: 30808575 DOI: 10.1016/j.clinre.2019.01.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
123 Izopet J, Tremeaux P, Marion O, Migueres M, Capelli N, Chapuy-regaud S, Mansuy J, Abravanel F, Kamar N, Lhomme S. Hepatitis E virus infections in Europe. Journal of Clinical Virology 2019;120:20-6. [DOI: 10.1016/j.jcv.2019.09.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
124 Mrzljak A, Dinjar-Kujundzic P, Vilibic-Cavlek T, Jemersic L, Prpic J, Dakovic-Rode O, Kolaric B, Vince A. Hepatitis E seroprevalence and associated risk factors in Croatian liver transplant recipients. Rev Soc Bras Med Trop 2019;52:e20190302. [PMID: 31618309 DOI: 10.1590/0037-8682-0302-2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
125 Beer A, Holzmann H, Pischke S, Behrendt P, Wrba F, Schlue J, Drebber U, Neudert B, Halilbasic E, Kreipe H, Lohse A, Sterneck M, Wedemeyer H, Manns M, Dienes HP. Chronic Hepatitis E is associated with cholangitis. Liver Int 2019;39:1876-83. [PMID: 31102493 DOI: 10.1111/liv.14137] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
126 Yoshida T, Takamura M, Goto R, Takeuchi S, Tsuchiya A, Kamimura K, Tasaki M, Nakagawa Y, Saito K, Tomita Y, Terai S. Efficacy and safety of ribavirin therapy for chronic hepatitis E after kidney transplantation. Hepatol Res 2019;49:1244-8. [PMID: 31077507 DOI: 10.1111/hepr.13363] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
127 Soon CF, Behrendt P, Todt D, Manns MP, Wedemeyer H, Sällberg Chen M, Cornberg M. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E. J Hepatol 2019;71:673-84. [PMID: 31203151 DOI: 10.1016/j.jhep.2019.06.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
128 Heo NY. [Hepatitis E Virus: Epidemiology, Diagnosis, and Management]. Korean J Gastroenterol 2019;74:130-6. [PMID: 31554028 DOI: 10.4166/kjg.2019.74.3.130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
129 Walker CM. Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections. Cold Spring Harb Perspect Med. 2019;9. [PMID: 29844218 DOI: 10.1101/cshperspect.a033472] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
130 von Felden J, Alric L, Pischke S, Aitken C, Schlabe S, Spengler U, Giordani MT, Schnitzler P, Bettinger D, Thimme R, Xhaard A, Binder M, Ayuk F, Lohse AW, Cornelissen JJ, de Man RA, Mallet V. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study. J Hepatol 2019;71:465-72. [PMID: 31108159 DOI: 10.1016/j.jhep.2019.04.022] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
131 Salines M, Rose N, Andraud M. Tackling hepatitis E virus spread and persistence on farrow-to-finish pig farms: Insights from a stochastic individual-based multi-pathogen model. Epidemics 2020;30:100369. [PMID: 31526684 DOI: 10.1016/j.epidem.2019.100369] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
132 Hartard C, Gantzer C, Bronowicki JP, Schvoerer E. Emerging hepatitis E virus compared with hepatitis A virus: A new sanitary challenge. Rev Med Virol 2019;29:e2078. [PMID: 31456241 DOI: 10.1002/rmv.2078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
133 Sridhar S, Cheng VCC, Wong SC, Yip CCY, Wu S, Lo AWI, Leung KH, Mak WWN, Cai J, Li X, Chan JFW, Lau SKP, Woo PCY, Lai WM, Kwan TH, Au TWK, Lo CM, Wong SCY, Yuen KY. Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018. Emerg Infect Dis 2019;25:425-33. [PMID: 30789146 DOI: 10.3201/eid2503.181563] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
134 Lemon SM, Walker CM. Enterically Transmitted Non-A, Non-B Hepatitis and the Discovery of Hepatitis E Virus. Cold Spring Harb Perspect Med 2019;9:a033449. [PMID: 29735576 DOI: 10.1101/cshperspect.a033449] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
135 Diebold M, Fischer-Barnicol B, Tsagkas C, Kuhle J, Kappos L, Derfuss T, Décard BF. Hepatitis E virus infections in patients with MS on oral disease-modifying treatment. Neurol Neuroimmunol Neuroinflamm 2019;6:e594. [PMID: 31454772 DOI: 10.1212/NXI.0000000000000594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
136 Xhaard A, Roque-Afonso AM, Mallet V, Ribaud P, Nguyen-Quoc S, Rohrlich PS, Tabrizi R, Konopacki J, Lissandre S, Abravanel F, Latour RP, Huynh A. Hepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective Study. Viruses 2019;11:E622. [PMID: 31284515 DOI: 10.3390/v11070622] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
137 Horvatits T, Schulze Zur Wiesch J, Lütgehetmann M, Lohse AW, Pischke S. The Clinical Perspective on Hepatitis E. Viruses 2019;11:E617. [PMID: 31284447 DOI: 10.3390/v11070617] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 11.8] [Reference Citation Analysis]
138 Kamar N, Pischke S. Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment. Cold Spring Harb Perspect Med 2019;9:a031872. [PMID: 29735575 DOI: 10.1101/cshperspect.a031872] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
139 Gallian P, Pouchol E, Djoudi R, Lhomme S, Mouna L, Gross S, Bierling P, Assal A, Kamar N, Mallet V, Roque-afonso A, Izopet J, Tiberghien P. Transfusion-Transmitted Hepatitis E Virus Infection in France. Transfusion Medicine Reviews 2019;33:146-53. [DOI: 10.1016/j.tmrv.2019.06.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
140 Miletić M, Vuk T, Hećimović A, Stojić Vidović M, Jemeršić L, Jukić I. Estimation of the hepatitis E assay-dependent seroprevalence among Croatian blood donors. Transfus Clin Biol 2019;26:229-33. [PMID: 31277986 DOI: 10.1016/j.tracli.2019.06.234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
141 Delage G, Fearon M, Gregoire Y, Hogema BM, Custer B, Scalia V, Hawes G, Bernier F, Nguyen ML, Stramer SL. Hepatitis E Virus Infection in Blood Donors and Risk to Patients in the United States and Canada. Transfus Med Rev 2019;33:139-45. [PMID: 31324552 DOI: 10.1016/j.tmrv.2019.05.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
142 Netzler NE, Enosi Tuipulotu D, Vasudevan SG, Mackenzie JM, White PA. Antiviral Candidates for Treating Hepatitis E Virus Infection. Antimicrob Agents Chemother. 2019;63. [PMID: 30885901 DOI: 10.1128/aac.00003-19] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
143 Salines M, Dumarest M, Andraud M, Mahé S, Barnaud E, Cineux M, Eveno E, Eono F, Dorenlor V, Grasland B, Bourry O, Pavio N, Rose N. Natural viral co-infections in pig herds affect hepatitis E virus (HEV) infection dynamics and increase the risk of contaminated livers at slaughter. Transbound Emerg Dis 2019;66:1930-45. [PMID: 31067014 DOI: 10.1111/tbed.13224] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
144 Primadharsini PP, Nagashima S, Okamoto H. Genetic Variability and Evolution of Hepatitis E Virus. Viruses 2019;11:E456. [PMID: 31109076 DOI: 10.3390/v11050456] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 13.5] [Reference Citation Analysis]
145 Lhomme S, Legrand-abravanel F, Kamar N, Izopet J. Screening, diagnosis and risks associated with Hepatitis E virus infection. Expert Review of Anti-infective Therapy 2019;17:403-18. [DOI: 10.1080/14787210.2019.1613889] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
146 Nam H, Nilles KM, Levitsky J, Ison MG. Donor-derived Viral Infections in Liver Transplantation. Transplantation 2018;102:1824-36. [PMID: 29979345 DOI: 10.1097/TP.0000000000002326] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
147 Friebus-Kardash J, Eisenberger U, Ackermann J, Kribben A, Witzke O, Wenzel J, Rohn H, Fiedler M. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients. Transpl Infect Dis 2019;21:e13088. [PMID: 30929308 DOI: 10.1111/tid.13088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
148 Te H, Doucette K. Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice. Clin Transplant 2019;33. [DOI: 10.1111/ctr.13514] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
149 McGivern DR, Lin HS, Wang J, Benzine T, Janssen HLA, Khalili M, Lisker-Melman M, Fontana RJ, Belle SH, Fried MW. Prevalence and Impact of Hepatitis E Virus Infection Among Persons With Chronic Hepatitis B Living in the US and Canada. Open Forum Infect Dis 2019;6:ofz175. [PMID: 31139669 DOI: 10.1093/ofid/ofz175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
150 Webb GW, Dalton HR. Hepatitis E: an underestimated emerging threat. Ther Adv Infect Dis. 2019;6:2049936119837162. [PMID: 30984394 DOI: 10.1177/2049936119837162] [Cited by in Crossref: 36] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
151 Cullen JM, Lemon SM. Comparative Pathology of Hepatitis A Virus and Hepatitis E Virus Infection. Cold Spring Harb Perspect Med 2019;9:a033456. [PMID: 29712683 DOI: 10.1101/cshperspect.a033456] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
152 Narayanan S, Abutaleb A, Sherman KE, Kottilil S. Clinical features and determinants of chronicity in hepatitis E virus infection. J Viral Hepat 2019;26:414-21. [PMID: 30636092 DOI: 10.1111/jvh.13059] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
153 Hofmeister MG, Foster MA, Teshale EH. Epidemiology and Transmission of Hepatitis A Virus and Hepatitis E Virus Infections in the United States. Cold Spring Harb Perspect Med. 2019;9. [PMID: 29712684 DOI: 10.1101/cshperspect.a033431] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
154 Ankcorn MJ, Ijaz S, Poh J, Elsharkawy AM, Smit E, Cramb R, Ravi S, Martin K, Tedder R, Neuberger J. Toward Systematic Screening for Persistent Hepatitis E Virus Infections in Transplant Patients. Transplantation 2018;102:1139-47. [PMID: 29953421 DOI: 10.1097/TP.0000000000002097] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
155 Zhang H, Rao H, Wang Y, Wang J, Kong X, Ji Y, Zhu L, Liu Y, Fang J, Yang M, Luo B, Wang Z, Shi Y, Wang Y, Wang H, Zhao J, Wei L. Evaluation of an antigen assay for diagnosing acute and chronic hepatitis E genotype 4 infection. J Gastroenterol Hepatol 2019;34:458-65. [PMID: 30069920 DOI: 10.1111/jgh.14405] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
156 Marion O, Capelli N, Lhomme S, Dubois M, Pucelle M, Abravanel F, Kamar N, Izopet J. Hepatitis E virus genotype 3 and capsid protein in the blood and urine of immunocompromised patients. J Infect 2019;78:232-40. [PMID: 30659856 DOI: 10.1016/j.jinf.2019.01.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
157 Meister TL, Bruening J, Todt D, Steinmann E. Cell culture systems for the study of hepatitis E virus. Antiviral Res 2019;163:34-49. [PMID: 30653997 DOI: 10.1016/j.antiviral.2019.01.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
158 Kenney SP, Meng XJ. Hepatitis E Virus Genome Structure and Replication Strategy. Cold Spring Harb Perspect Med 2019;9:a031724. [PMID: 29530948 DOI: 10.1101/cshperspect.a031724] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 16.3] [Reference Citation Analysis]
159 Sue PK, Karnsakul W. Hepatitis E Virus Infection in Children. Viral Hepatitis in Children 2019. [DOI: 10.1007/978-981-13-0050-9_14] [Reference Citation Analysis]
160 Doucette K, Kamar N. Prevention and Treatment of Viral Hepatitis. Infectious Diseases in Solid-Organ Transplant Recipients 2019. [DOI: 10.1007/978-3-030-15394-6_10] [Reference Citation Analysis]
161 Khuroo MS. A Review of Acute Viral Hepatitides Including Hepatitis E. Viral Hepatitis: Acute Hepatitis 2019. [DOI: 10.1007/978-3-030-03535-8_6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
162 Ghufran A. Viral Hepatitis: Hepatitis B, D, and E Viruses. Gastrointestinal and Liver Disorders in Women’s Health 2019. [DOI: 10.1007/978-3-030-25626-5_17] [Reference Citation Analysis]
163 Khuroo MS, Khuroo MS, Khuroo NS. Enteric Hepatitis Viruses: Hepatitis A Virus and Hepatitis E Virus. Clinical Epidemiology of Chronic Liver Diseases 2019. [DOI: 10.1007/978-3-319-94355-8_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
164 Nelson KE, Kmush BL. Epidemiology of Viral Hepatitis A and E: A Global View. Viral Hepatitis in Children 2019. [DOI: 10.1007/978-981-13-0050-9_2] [Reference Citation Analysis]
165 Mohanraj BS, Rangnekar AS, Timpone JG. Infections in Liver Transplantation. Principles and Practice of Transplant Infectious Diseases 2019. [DOI: 10.1007/978-1-4939-9034-4_3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
166 Fischer SA. Is This Organ Donor Safe?: Donor-Derived Infections in Solid Organ Transplantation. Infect Dis Clin North Am 2018;32:495-506. [PMID: 30146019 DOI: 10.1016/j.idc.2018.04.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
167 Vanichanan J, Udomkarnjananun S, Avihingsanon Y, Jutivorakool K. Common viral infections in kidney transplant recipients. Kidney Res Clin Pract 2018;37:323-37. [PMID: 30619688 DOI: 10.23876/j.krcp.18.0063] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 8.4] [Reference Citation Analysis]
168 Nanmoku K, Owada Y, Oshiro Y, Kurosawa A, Kubo T, Shinzato T, Shimizu T, Kimura T, Sakuma Y, Ishikawa N, Ohkohchi N, Okamoto H, Yagisawa T. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan. Transpl Infect Dis 2019;21:e13033. [PMID: 30481402 DOI: 10.1111/tid.13033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
169 Fischer SA. Is This Organ Donor Safe?: Donor-Derived Infections in Solid Organ Transplantation. Surg Clin North Am 2019;99:117-28. [PMID: 30471737 DOI: 10.1016/j.suc.2018.09.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
170 Lim MA, Kamili S, Cohen JB, Green-Montfort T, Tejada-Strop A, Kohli J, Drobeniuc J, Patel P, Vanderveen M, Bloom RD. Hepatitis E Virus Infection in Kidney Transplant Patients: A Single-Center Study. Transplantation. 2018;102:e126-e127. [PMID: 29329183 DOI: 10.1097/tp.0000000000002071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
171 Parfieniuk-Kowerda A, Jaroszewicz J, Łapiński TW, Łucejko M, Maciaszek M, Świderska M, Grzeszczuk A, Naumnik B, Rowiński M, Flisiak R. High prevalence of anti-HEV antibodies among patients with immunosuppression and hepatic disorders in eastern Poland. Arch Med Sci 2021;17:675-81. [PMID: 34025837 DOI: 10.5114/aoms.2018.79958] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
172 Marion O, Abravanel F, Del Bello A, Esposito L, Lhomme S, Puissant-Lubrano B, Alric L, Faguer S, Izopet J, Kamar N. Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients. Liver Int 2018;38:2178-89. [PMID: 29845733 DOI: 10.1111/liv.13894] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
173 Tang F, Mo X, Wang Y, Yan C, Chen Y, Chen H, Han W, Chang Y, Zhang H, Xie Y, Ma H, Wei L, Xu L, Huang X, Zhang X. Hepatitis E virus infection after haploidentical haematopoietic stem cell transplantation: incidence and clinical course. Br J Haematol 2019;184:788-96. [DOI: 10.1111/bjh.15672] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
174 Belbézier A, Lagrange E, Bouillet L. Trouble neurologique et hépatite E : revue de la littérature. La Revue de Médecine Interne 2018;39:842-8. [DOI: 10.1016/j.revmed.2018.06.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
175 Faria LC, Terrabuio DRB, Leblebicioglu H, Huprikar S. Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation 2018;102:S66-71. [PMID: 29381580 DOI: 10.1097/TP.0000000000002013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
176 Darstein F, Häuser F, Straub BK, Wenzel JJ, Conradi R, Mittler J, Lang H, Galle PR, Zimmermann T. Hepatitis E virus genotype 3 is a common finding in liver-transplanted patients undergoing liver biopsy for elevated liver enzymes with a low De Ritis ratio and suspected acute rejection: A real-world cohort: XXXX. Clin Transplant 2018;32:e13411. [DOI: 10.1111/ctr.13411] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
177 Kamp C, Blümel J, Baylis SA, Bekeredjian-Ding I, Chudy M, Heiden M, Henseler O, Keller-Stanislawski B, de Vos AS, Funk MB. Impact of hepatitis E virus testing on the safety of blood components in Germany - results of a simulation study. Vox Sang 2018;113:811-3. [PMID: 30318777 DOI: 10.1111/vox.12719] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
178 Yugo DM, Heffron CL, Ryu J, Uh K, Subramaniam S, Matzinger SR, Overend C, Cao D, Kenney SP, Sooryanarain H, Cecere T, LeRoith T, Yuan L, Jue N, Clark-Deener S, Lee K, Meng XJ. Infection Dynamics of Hepatitis E Virus in Wild-Type and Immunoglobulin Heavy Chain Knockout JH -/- Gnotobiotic Piglets. J Virol 2018;92:e01208-18. [PMID: 30111571 DOI: 10.1128/JVI.01208-18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
179 Bottino FO, Gardinali NR, Salvador SBS, Figueiredo AS, Cysne LB, Francisco JS, de Oliveira JM, Machado MP, Pinto MA. Cynomolgus monkeys (Macaca fascicularis) experimentally and naturally infected with hepatitis E virus: The bone marrow as a possible new viral target. PLoS One 2018;13:e0205039. [PMID: 30278075 DOI: 10.1371/journal.pone.0205039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
180 Cella E, Golkocheva-Markova E, Sagnelli C, Scolamacchia V, Bruni R, Villano U, Ciccaglione AR, Equestre M, Sagnelli E, Angeletti S, Ciccozzi M. Human hepatitis E virus circulation in Bulgaria: Deep Bayesian phylogenetic analysis for viral spread control in the country. J Med Virol. 2019;91:132-138. [PMID: 30168583 DOI: 10.1002/jmv.25296] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
181 McPherson S, Elsharkawy AM, Ankcorn M, Ijaz S, Powell J, Rowe I, Tedder R, Andrews PA. Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation. Transplantation. 2018;102:15-20. [PMID: 28795981 DOI: 10.1097/tp.0000000000001908] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
182 Okamoto H. 2. Hepatitis E: Frontier of Medical Practice. J Jpn Soc Intern Med 2018;107:1826-1832. [DOI: 10.2169/naika.107.1826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
183 Allaire M, Bazille C, Selves J, Salamé E, Altieri M. Hepatitis E virus infection mimicking acute graft rejection in a liver transplant recipient. Clin Res Hepatol Gastroenterol 2018;42:e68-71. [PMID: 29650438 DOI: 10.1016/j.clinre.2017.12.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
184 Buganza-torio E, Doucette KE. Management of Viral Hepatitis in Solid Organ Transplant Recipients. Infectious Disease Clinics of North America 2018;32:635-50. [DOI: 10.1016/j.idc.2018.04.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
185 Soothill G, Hessey S, Erotocritou M, Griffiths P, Ijaz S, Thorburn D, Ankcorn M, Irish D. Diagnostic utility of hepatitis E virus antigen-specific ELISA versus PCR testing in a cohort of post liver transplant patients in a large university hospital. Journal of Clinical Virology 2018;106:44-8. [DOI: 10.1016/j.jcv.2018.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
186 Mallet V, Sberro-soussan R, Roque-afonso A, Vallet-pichard A, Deau B, Portal A, Chaix M, Hauser L, Beylouné A, Mercadier A, Izopet J, Legendre C, Pol S. Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study. Transplantation 2018;102:1351-7. [DOI: 10.1097/tp.0000000000002185] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
187 Salines M, Andraud M, Terrade F, Rose N. Are French pig farmers and veterinarians knowledgeable about emerging foodborne pathogens? The case of hepatitis E virus. Preventive Veterinary Medicine 2018;156:1-7. [DOI: 10.1016/j.prevetmed.2018.04.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
188 Ikeuchi H, Koinuma K, Nakasatomi M, Sakairi T, Kaneko Y, Maeshima A, Yamazaki Y, Okamoto H, Mimura T, Mochida S, Nojima Y, Hiromura K. Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review. Case Rep Rheumatol 2018;2018:6873276. [PMID: 30147981 DOI: 10.1155/2018/6873276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
189 Diehl TM, Adams DJ, Nylund CM. Ingesting Self-Grown Produce and Seropositivity for Hepatitis E in the United States. Gastroenterol Res Pract 2018;2018:7980413. [PMID: 30116267 DOI: 10.1155/2018/7980413] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
190 Wen GP, Chen CR, Song XY, Tang ZM, Ji WF, Wang SL, Zhang K, Zhang J, Ou SH, Zheng ZZ, Xia NS. Long-term HEV carriers without antibody seroconversion among eligible immunocompetent blood donors. Emerg Microbes Infect. 2018;7:125. [PMID: 29977038 DOI: 10.1038/s41426-018-0125-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
191 Lenggenhager D, Weber A. An Update on the Clinicopathologic Features and Pathologic Diagnosis of Hepatitis E in Liver Specimens. Adv Anat Pathol 2018;25:273-81. [PMID: 29697415 DOI: 10.1097/PAP.0000000000000195] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
192 Gupta E, Agarwala P. Hepatitis E Virus Infection: An Old Virus with a New Story! Indian Journal of Medical Microbiology 2018;36:317-23. [DOI: 10.4103/ijmm.ijmm_18_149] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
193 Anang S, Kaushik N, Surjit M. Recent Advances Towards the Development of a Potent Antiviral Against the Hepatitis E Virus. J Clin Transl Hepatol 2018;6:310-6. [PMID: 30271744 DOI: 10.14218/JCTH.2018.00005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
194 Bettinger D, Schlabe S, Pischke S, Mallmann MR, Keyver-Paik MD, Kuhn W, Strassburg CP, Thimme R, Spengler U. Ribavirin in Acute Hepatitis E Infection in Patients with Gynecological Cancer: A Case Series. J Clin Transl Hepatol 2018;6:237-40. [PMID: 29951369 DOI: 10.14218/JCTH.2017.00063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
195 Brahmbhatt RD, Lok ASF. Enterically Transmitted Viral Hepatitis. Sherlock's Diseases of the Liver and Biliary System 2018. [DOI: 10.1002/9781119237662.ch20] [Reference Citation Analysis]
196 Alnuaimi K, Lavolé J, Lascoux-Combes C, Roque Afonso AM, Sogni P, Pol S, Mallet V. Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine. Hepatology 2018;67:2468-70. [PMID: 29194671 DOI: 10.1002/hep.29697] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
197 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol 2018;68:1256-71. [PMID: 29609832 DOI: 10.1016/j.jhep.2018.03.005] [Cited by in Crossref: 293] [Cited by in F6Publishing: 279] [Article Influence: 58.6] [Reference Citation Analysis]
198 Wang M, Huang Y, He M, Peng WJ, Tian DY. Effects of hepatitis E virus infection on interferon production via ISG15. World J Gastroenterol 2018; 24(20): 2173-2180 [PMID: 29853735 DOI: 10.3748/wjg.v24.i20.2173] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
199 Capai L, Charrel R, Falchi A. Hepatitis E in High-Income Countries: What Do We Know? And What Are the Knowledge Gaps? Viruses 2018;10:E285. [PMID: 29799485 DOI: 10.3390/v10060285] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
200 Wang B, Harms D, Papp CP, Niendorf S, Jacobsen S, Lütgehetmann M, Pischke S, Wedermeyer H, Hofmann J, Bock CT. Comprehensive Molecular Approach for Characterization of Hepatitis E Virus Genotype 3 Variants. J Clin Microbiol 2018;56:e01686-17. [PMID: 29514938 DOI: 10.1128/JCM.01686-17] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
201 Shindo M, Takemae H, Kubo T, Soeno M, Ando T, Morishita Y. Acute hepatitis E in a renal transplantation recipient: a case report. Int Med Case Rep J 2018;11:77-80. [PMID: 29670408 DOI: 10.2147/IMCRJ.S163865] [Reference Citation Analysis]
202 Cordts SE, Schneble L, Schnitzler P, Wenzel JJ, Vinke T, Rieger S, Fichtner A, Tönshoff B, Höcker B. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients. Pediatr Nephrol 2018;33:1215-25. [DOI: 10.1007/s00467-018-3905-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
203 Wang Y, Chen G, Pan Q, Zhao J. Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient. Gastroenterology 2018;154:1199-201. [PMID: 29432746 DOI: 10.1053/j.gastro.2017.12.028] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
204 Agarwala P, Gupta E, Choudhary MC, Pamecha V. Absence of chronic hepatitis E virus infection in liver transplant recipients: Report from a hyperendemic region. Indian J Gastroenterol 2018;37:160-3. [PMID: 29552742 DOI: 10.1007/s12664-018-0840-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
205 De Winter BCM, Hesselink DA, Kamar N. Dosing ribavirin in hepatitis E-infected solid organ transplant recipients. Pharmacol Res 2018;130:308-15. [PMID: 29499270 DOI: 10.1016/j.phrs.2018.02.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
206 O'Gorman J, Burke Á, O'Flaherty N. Hepatitis E virus - key points for the clinical haematologist. Br J Haematol 2018;181:579-89. [PMID: 29468650 DOI: 10.1111/bjh.15133] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
207 Nicolini LA, Zappulo E, Viscoli C, Mikulska M. Management of chronic viral hepatitis in the hematological patient. Expert Rev Anti Infect Ther 2018;16:227-41. [PMID: 29415584 DOI: 10.1080/14787210.2018.1438264] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
208 Izopet J. [HEV and transfusion-recipient risk]. Ann Pharm Fr 2018;76:89-96. [PMID: 29395014 DOI: 10.1016/j.pharma.2017.12.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
209 Choi M, Hofmann J, Köhler A, Wang B, Bock CT, Schott E, Reinke P, Nickel P. Prevalence and Clinical Correlates of Chronic Hepatitis E Infection in German Renal Transplant Recipients With Elevated Liver Enzymes. Transplant Direct 2018;4:e341. [PMID: 29464202 DOI: 10.1097/TXD.0000000000000758] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
210 Nimgaonkar I, Ding Q, Schwartz RE, Ploss A. Hepatitis E virus: advances and challenges. Nat Rev Gastroenterol Hepatol 2018;15:96-110. [PMID: 29162935 DOI: 10.1038/nrgastro.2017.150] [Cited by in Crossref: 146] [Cited by in F6Publishing: 141] [Article Influence: 29.2] [Reference Citation Analysis]
211 Heil J, Hoebe CJPA, Loo IHMV, Cals JWL, van Liere GAFS, Dukers-Muijrers NHTM. Hepatitis E prevalence in a sexual high-risk population compared to the general population. PLoS One 2018;13:e0191798. [PMID: 29370254 DOI: 10.1371/journal.pone.0191798] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
212 Benamu E, Wolfe CR, Montoya JG. Donor-derived infections in solid organ transplant patients: toward a holistic approach. Curr Opin Infect Dis 2017;30:329-39. [PMID: 28538045 DOI: 10.1097/QCO.0000000000000377] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
213 Dalton HR, Izopet J, Xia N. Hepatitis E Vaccines. Plotkin's Vaccines 2018. [DOI: 10.1016/b978-0-323-35761-6.00027-4] [Reference Citation Analysis]
214 Clouston AD, Hübscher SG. Transplantation Pathology. Macsween's Pathology of the Liver 2018. [DOI: 10.1016/b978-0-7020-6697-9.00014-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
215 Sherman KE, Sterling RK. HIV and the Liver. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00037-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
216 Dalton HR, Izopet J, Bendall R. Hepatitis E. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00036-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
217 Masia R, Misdraji J. Liver and Bile Duct Infections. Diagnostic Pathology of Infectious Disease 2018. [DOI: 10.1016/b978-0-323-44585-6.00011-4] [Reference Citation Analysis]
218 Nguyen KT, Han SB. Hepatitis A and Hepatitis E. Handbook of Liver Disease 2018. [DOI: 10.1016/b978-0-323-47874-8.00003-1] [Reference Citation Analysis]
219 Hakim MS, Ikram A, Zhou J, Wang W, Peppelenbosch MP, Pan Q. Immunity against hepatitis E virus infection: Implications for therapy and vaccine development. Rev Med Virol. 2018;28. [PMID: 29272060 DOI: 10.1002/rmv.1964] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
220 Nan Y, Wu C, Zhao Q, Zhou EM. Zoonotic Hepatitis E Virus: An Ignored Risk for Public Health. Front Microbiol 2017;8:2396. [PMID: 29255453 DOI: 10.3389/fmicb.2017.02396] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 7.7] [Reference Citation Analysis]
221 Pavio N, Doceul V, Bagdassarian E, Johne R. Recent knowledge on hepatitis E virus in Suidae reservoirs and transmission routes to human. Vet Res 2017;48:78. [PMID: 29157309 DOI: 10.1186/s13567-017-0483-9] [Cited by in Crossref: 98] [Cited by in F6Publishing: 100] [Article Influence: 16.3] [Reference Citation Analysis]
222 Kamar N, Izopet J, Pavio N, Aggarwal R, Labrique A, Wedemeyer H, Dalton HR. Hepatitis E virus infection. Nat Rev Dis Primers. 2017;3:17086. [PMID: 29154369 DOI: 10.1038/nrdp.2017.86] [Cited by in Crossref: 271] [Cited by in F6Publishing: 282] [Article Influence: 45.2] [Reference Citation Analysis]
223 Haffar S, Bazerbachi F, Leise MD, Dillon JJ, Albright RC, Murad MH, Kamath PS, Watt KD. Systematic review with meta-analysis: the association between hepatitis E seroprevalence and haemodialysis. Aliment Pharmacol Ther 2017;46:790-9. [PMID: 28869287 DOI: 10.1111/apt.14285] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
224 Sherman KE, Kottilil S. Hepatitis A and E. Schiff's Diseases of the Liver 2017. [DOI: 10.1002/9781119251316.ch23] [Reference Citation Analysis]
225 Nelson KE, Heaney CD, Labrique AB, Kmush BL, Krain LJ. Hepatitis E: prevention and treatment. Curr Opin Infect Dis 2016;29:478-85. [PMID: 27454402 DOI: 10.1097/QCO.0000000000000294] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
226 Zhang J, Zhao Q, Xia N. Prophylactic Hepatitis E Vaccine. Adv Exp Med Biol 2016;948:223-46. [PMID: 27738988 DOI: 10.1007/978-94-024-0942-0_13] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
227 Lenggenhager D, Gouttenoire J, Malehmir M, Bawohl M, Honcharova-Biletska H, Kreutzer S, Semela D, Neuweiler J, Hürlimann S, Aepli P, Fraga M, Sahli R, Terracciano L, Rubbia-Brandt L, Müllhaupt B, Sempoux C, Moradpour D, Weber A. Visualization of hepatitis E virus RNA and proteins in the human liver. J Hepatol 2017;67:471-9. [PMID: 28412294 DOI: 10.1016/j.jhep.2017.04.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
228 Mazzola A, Tran Minh M, Charlotte F, Hdiji A, Bernard D, Wendum D, Calmus Y, Conti F. Chronic Hepatitis E Viral Infection After Liver Transplantation: A Regression of Fibrosis After Antiviral Therapy. Transplantation 2017;101:2083-7. [DOI: 10.1097/tp.0000000000001766] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
229 Guerra JAAA, Kampa KC, Morsoletto DGB, Junior AP, Ivantes CAP. Hepatitis E: A Literature Review. J Clin Transl Hepatol. 2017;5:376-383. [PMID: 29226104 DOI: 10.14218/jcth.2017.00012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
230 van de Garde MDB, Pas SD, van Oord GW, Gama L, Choi Y, de Man RA, Boonstra A, Vanwolleghem T. Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice. Sci Rep 2017;7:8267. [PMID: 28811492 DOI: 10.1038/s41598-017-07434-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
231 Fang SY, Han H. Hepatitis E viral infection in solid organ transplant patients: . Current Opinion in Organ Transplantation 2017;22:351-5. [DOI: 10.1097/mot.0000000000000432] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
232 Ankcorn MJ, Tedder RS. Hepatitis E: the current state of play. Transfus Med 2017;27:84-95. [PMID: 28382704 DOI: 10.1111/tme.12405] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
233 O'Donghaile D, O'Flaherty N, Field S. Early hepatitis E infection in an unrelated hematopoietic progenitor stem cell donor. Bone Marrow Transplant 2017;52:1471-2. [PMID: 28714948 DOI: 10.1038/bmt.2017.163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
234 Izopet J, Lhomme S, Chapuy-Regaud S, Mansuy JM, Kamar N, Abravanel F. HEV and transfusion-recipient risk. Transfus Clin Biol 2017;24:176-81. [PMID: 28690036 DOI: 10.1016/j.tracli.2017.06.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
235 Donnelly MC, Scobie L, Crossan CL, Dalton H, Hayes PC, Simpson KJ. Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy. Aliment Pharmacol Ther 2017;46:126-41. [PMID: 28449246 DOI: 10.1111/apt.14109] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 9.2] [Reference Citation Analysis]
236 Murkey JA, Chew KW, Carlson M, Shannon CL, Sirohi D, Sample HA, Wilson MR, Vespa P, Humphries RM, Miller S, Klausner JD, Chiu CY. Hepatitis E Virus-Associated Meningoencephalitis in a Lung Transplant Recipient Diagnosed by Clinical Metagenomic Sequencing. Open Forum Infect Dis. 2017;4:ofx121. [PMID: 28721353 DOI: 10.1093/ofid/ofx121] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 7.7] [Reference Citation Analysis]
237 Salines M, Andraud M, Rose N. From the epidemiology of hepatitis E virus (HEV) within the swine reservoir to public health risk mitigation strategies: a comprehensive review. Vet Res. 2017;48:31. [PMID: 28545558 DOI: 10.1186/s13567-017-0436-3] [Cited by in Crossref: 87] [Cited by in F6Publishing: 89] [Article Influence: 14.5] [Reference Citation Analysis]
238 Bazerbachi F, Leise MD, Watt KD, Murad MH, Prokop LJ, Haffar S. Systematic review of mixed cryoglobulinemia associated with hepatitis E virus infection: association or causation? Gastroenterol Rep (Oxf). 2017;5:178-184. [PMID: 28852522 DOI: 10.1093/gastro/gox021] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 7.2] [Reference Citation Analysis]
239 Li IWS, Chok KSH. Acute hepatitis E virus infection causing acute liver failure requiring living-donor liver transplantation in a non-pregnant immunocompetent woman. Transpl Infect Dis 2017;19. [PMID: 28295889 DOI: 10.1111/tid.12699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
240 Shrestha A, P Gupta B, K Lama T. Current Treatment of Acute and Chronic Hepatitis E Virus Infection: Role of Antivirals. Euroasian J Hepatogastroenterol. 2017;7:73-77. [PMID: 29201777 DOI: 10.5005/jp-journals-10018-1216] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
241 Mihalčin M, Fašaneková L, Husa P, Husa P. Current opinion in epidemiology and approaches to the treatment of viral hepatitis A and E. Klin Farmakol Farm 2017;31:15-18. [DOI: 10.36290/far.2017.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
242 Pischke S, Hartl J, Pas SD, Lohse AW, Jacobs BC, Van der Eijk AA. Hepatitis E virus: Infection beyond the liver? J Hepatol 2017;66:1082-95. [PMID: 27913223 DOI: 10.1016/j.jhep.2016.11.016] [Cited by in Crossref: 130] [Cited by in F6Publishing: 125] [Article Influence: 21.7] [Reference Citation Analysis]
243 Nelson KE, Heaney CD, Kmush BL. The Epidemiology and Prevention of Hepatitis E Virus Infection. Curr Epidemiol Rep 2017;4:186-98. [DOI: 10.1007/s40471-017-0109-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
244 van der Eijk AA, Pas SD, de Man RA. Hepatitis E virus: A potential threat for patients with liver disease and liver transplantation. Best Pract Res Clin Gastroenterol 2017;31:143-50. [PMID: 28624102 DOI: 10.1016/j.bpg.2017.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
245 Gardinali NR, Guimarães JR, Melgaço JG, Kevorkian YB, Bottino FO, Vieira YR, da Silva AC, Pinto DP, da Fonseca LB, Vilhena LS, Uiechi E, da Silva MC, Moran J, Marchevsky RS, Cruz OG, Otonel RA, Alfieri AA, de Oliveira JM, Gaspar AM, Pinto MA. Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy. PLoS One 2017;12:e0174070. [PMID: 28328941 DOI: 10.1371/journal.pone.0174070] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
246 van Dijk WEM, Vergeer MAMH, Arends JE. Persistent Hepatitis E Infection in a Patient with Tuberous Sclerosis Complex Treated with Everolimus: A Case Report. Infect Dis Ther 2017;6:291-5. [PMID: 28258506 DOI: 10.1007/s40121-017-0147-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
247 Germer JJ, Ankoudinova I, Belousov YS, Mahoney W, Dong C, Meng J, Mandrekar JN, Yao JD. Hepatitis E Virus (HEV) Detection and Quantification by a Real-Time Reverse Transcription-PCR Assay Calibrated to the World Health Organization Standard for HEV RNA. J Clin Microbiol 2017;55:1478-87. [PMID: 28228493 DOI: 10.1128/JCM.02334-16] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
248 Satake M, Matsubayashi K, Hoshi Y, Taira R, Furui Y, Kokudo N, Akamatsu N, Yoshizumi T, Ohkohchi N, Okamoto H, Miyoshi M, Tamura A, Fuse K, Tadokoro K. Unique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppression. Transfusion. 2017;57:280-288. [PMID: 28144952 DOI: 10.1111/trf.13994] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 8.2] [Reference Citation Analysis]
249 de Vos AS, Janssen MP, Zaaijer HL, Hogema BM. Cost-effectiveness of the screening of blood donations for hepatitis E virus in the Netherlands: COST-EFFECTIVENESS HEV SCREENING IN THE NETHERLANDS. Transfusion 2017;57:258-66. [DOI: 10.1111/trf.13978] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
250 Teo EC, Tan BH, Purdy MA, Wong PS, Ting PJ, Chang PJ, Oon LL, Sue A, Teo CG, Tan CK. Hepatitis E in Singapore: A Case-Series and Viral Phylodynamics Study. Am J Trop Med Hyg 2017;96:922-8. [PMID: 28093535 DOI: 10.4269/ajtmh.16-0482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
251 Pourbaix A, Ouali N, Soussan P, Roque Afonso AM, Péraldi MN, Rondeau E, Peltier J. Evidence of hepatitis E virus transmission by renal graft. Transpl Infect Dis 2017;19. [PMID: 27775205 DOI: 10.1111/tid.12624] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
252 Fong IW. Hepatitis E: A Zoonosis. Emerging Zoonoses 2017. [DOI: 10.1007/978-3-319-50890-0_8] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
253 Yurdaydin C. Immunohistochemistry for Viral Hepatitis: Methods and Applications. Biomarkers in Disease: Methods, Discoveries and Applications 2017. [DOI: 10.1007/978-94-007-7675-3_45] [Reference Citation Analysis]
254 Spearman CW, de Lacy R, Goddard E. Viral Hepatitis. Viral Infections in Children, Volume II 2017. [DOI: 10.1007/978-3-319-54093-1_7] [Reference Citation Analysis]
255 Wyles D, Lin J. Clinical Manifestations of Acute and Chronic Hepatitis. Infectious Diseases 2017. [DOI: 10.1016/b978-0-7020-6285-8.00042-3] [Reference Citation Analysis]
256 Pisano MB, Balderramo D, Wassaf MM, Lotto M, Carlino Y, Ré VE, Debes JD. Hepatitis E virus infection in patients on dialysis and in solid organ transplant recipients in Argentina: exploring associated risk factors. Arch Virol 2017;162:787-92. [DOI: 10.1007/s00705-016-3171-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
257 Inagaki Y, Oshiro Y, Tanaka T, Yoshizumi T, Okajima H, Ishiyama K, Nakanishi C, Hidaka M, Wada H, Hibi T, Takagi K, Honda M, Kuramitsu K, Tanaka H, Tohyama T, Ikegami T, Imura S, Shimamura T, Nakayama Y, Urahashi T, Yamagishi K, Ohnishi H, Nagashima S, Takahashi M, Shirabe K, Kokudo N, Okamoto H, Ohkohchi N. A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis E in Liver Transplant Recipients in Japan. EBioMedicine 2015;2:1607-12. [PMID: 26870785 DOI: 10.1016/j.ebiom.2015.09.030] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
258 Hartl J, Wehmeyer MH, Pischke S. Acute Hepatitis E: Two Sides of the Same Coin. Viruses 2016;8:E299. [PMID: 27827877 DOI: 10.3390/v8110299] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
259 Mora Soler AM, Velasco-guardado A, Martín Arribas MI, Acosta Materan R, Revilla Morato C, Pérez Corte D, Rodríguez Pérez A. Chronic hepatitis caused by hepatitis E virus and treated with ribavirin. Gastroenterología y Hepatología (English Edition) 2016;39:597-598. [DOI: 10.1016/j.gastre.2016.10.003] [Reference Citation Analysis]
260 Riveiro-Barciela M, Sauleda S, Quer J, Salvador F, Gregori J, Pirón M, Rodríguez-Frías F, Buti M. Red blood cell transfusion-transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report. Transfusion 2017;57:244-7. [PMID: 27785789 DOI: 10.1111/trf.13876] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
261 Mora Soler AM, Velasco-Guardado A, Martín Arribas MI, Acosta Materan R, Revilla Morato C, Pérez Corte D, Rodríguez Pérez A. [Chronic hepatitis caused by hepatitis E virus and treated with ribavirin]. Gastroenterol Hepatol 2016;39:597-8. [PMID: 26589539 DOI: 10.1016/j.gastrohep.2015.09.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
262 Gouttenoire J, Szkolnicka D, Moradpour D. Treatment of chronic hepatitis E with ribavirin: lessons from deep sequencing. Gut 2016;65:1583-4. [PMID: 27335028 DOI: 10.1136/gutjnl-2016-312040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
263 Miyoshi M, Kakinuma S, Tanabe Y, Ishii K, Li TC, Wakita T, Tsuura Y, Watanabe H, Asahina Y, Watanabe M, Ikeda T. Chronic Hepatitis E Infection in a Persistently Immunosuppressed Patient Unable to Be Eliminated after Ribavirin Therapy. Intern Med 2016;55:2811-7. [PMID: 27725541 DOI: 10.2169/internalmedicine.55.7025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
264 Debing Y, Ramière C, Dallmeier K, Piorkowski G, Trabaud MA, Lebossé F, Scholtès C, Roche M, Legras-Lachuer C, de Lamballerie X, André P, Neyts J. Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity. J Hepatol 2016;65:499-508. [PMID: 27174035 DOI: 10.1016/j.jhep.2016.05.002] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 11.7] [Reference Citation Analysis]
265 Gajurel K, Stapleton JT. Hepatitis Viruses in Kidney Transplantation. Seminars in Nephrology 2016;36:386-96. [DOI: 10.1016/j.semnephrol.2016.05.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
266 Khuroo MS, Khuroo MS, Khuroo NS. Hepatitis E: Discovery, global impact, control and cure. World J Gastroenterol 2016; 22(31): 7030-7045 [PMID: 27610014 DOI: 10.3748/wjg.v22.i31.7030] [Cited by in CrossRef: 96] [Cited by in F6Publishing: 100] [Article Influence: 13.7] [Reference Citation Analysis]
267 Kamar N, Lhomme S, Abravanel F, Marion O, Peron JM, Alric L, Izopet J. Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis. Viruses 2016;8:E222. [PMID: 27537905 DOI: 10.3390/v8080222] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
268 O'riordan J, Boland F, Williams P, Donnellan J, Hogema BM, Ijaz S, Murphy WG. Hepatitis E virus infection in the Irish blood donor population: HEV INFECTION IN IRISH BLOOD DONORS. Transfusion 2016;56:2868-76. [DOI: 10.1111/trf.13757] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
269 Lhomme S, Marion O, Abravanel F, Chapuy-Regaud S, Kamar N, Izopet J. Hepatitis E Pathogenesis. Viruses. 2016;8. [PMID: 27527210 DOI: 10.3390/v8080212] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 9.3] [Reference Citation Analysis]
270 Doycheva I, Gallegos-orozco JF. Acute Viral Hepatitis: Hepatitis A, Hepatitis E, and Other Viruses. Practical Gastroenterology and Hepatology Board Review Toolkit 2016. [DOI: 10.1002/9781119127437.ch75] [Reference Citation Analysis]
271 Fischler B, Baumann U, Dezsofi A, Hadzic N, Hierro L, Jahnel J, McLin V, Nobili V, Smets F, Verkade H, Debray D. Hepatitis E in Children: A Position Paper by the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 2016;63:288-94. [PMID: 27050048 DOI: 10.1097/MPG.0000000000001231] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
272 Carmo J, Marques S, Mateus É, Morbey A, Veloso J, Almeida-Santos M, Curran M, Barroso E. Ribavirin for Chronic Hepatitis E in Liver-Transplant Setting: A Safe and Highly Effective Therapy. J Clin Gastroenterol 2016;50:608. [PMID: 27306937 DOI: 10.1097/MCG.0000000000000554] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
273 Debing Y, Mishra N, Verbeken E, Ramaekers K, Dallmeier K, Neyts J. A rat model for hepatitis E virus. Dis Model Mech 2016;9:1203-10. [PMID: 27483350 DOI: 10.1242/dmm.024406] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
274 Borg BB, Feng Z, Earl TM, Anderson CD. Hepatitis E in post-liver transplantation: is it time to routinely consider it? Clin Transplant 2016;30:975-9. [DOI: 10.1111/ctr.12777] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
275 Debing Y, Moradpour D, Neyts J, Gouttenoire J. Update on hepatitis E virology: Implications for clinical practice. J Hepatol 2016;65:200-12. [PMID: 26966047 DOI: 10.1016/j.jhep.2016.02.045] [Cited by in Crossref: 133] [Cited by in F6Publishing: 127] [Article Influence: 19.0] [Reference Citation Analysis]
276 Servant-Delmas A, Abravanel F, Lefrère JJ, Lionnet F, Hamon C, Izopet J, Laperche S. New insights into the natural history of hepatitis E virus infection through a longitudinal study of multitransfused immunocompetent patients in France. J Viral Hepat 2016;23:569-75. [PMID: 26990022 DOI: 10.1111/jvh.12531] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
277 Drave SA, Debing Y, Walter S, Todt D, Engelmann M, Friesland M, Wedemeyer H, Neyts J, Behrendt P, Steinmann E. Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells. J Viral Hepat 2016;23:512-21. [PMID: 26891712 DOI: 10.1111/jvh.12515] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 12.6] [Reference Citation Analysis]
278 Zeraati AA, Nazemian F, Takalloo L, Sahebkar A, Heidari E, Yaghoubi MA. The relationship between serology of hepatitis E virus with liver and kidney function in kidney transplant patients. EXCLI J 2016;15:343-9. [PMID: 27366144 DOI: 10.17179/excli2016-232] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
279 Liu L, Liu Y, Du Y, Liu C, Li W, Li H, Jia T, Chang L. Analysis of long-term follow-up and examination of pathological liver tissue in chronic hepatitis E. Dig Liver Dis 2016;48:684-6. [PMID: 27038702 DOI: 10.1016/j.dld.2016.02.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
280 Behrendt P, Bremer B, Todt D, Brown RJ, Heim A, Manns MP, Steinmann E, Wedemeyer H. Hepatitis E Virus (HEV) ORF2 Antigen Levels Differentiate Between Acute and Chronic HEV Infection. J Infect Dis. 2016;214:361-368. [PMID: 27234418 DOI: 10.1093/infdis/jiw161] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
281 Goel A, Aggarwal R. Advances in hepatitis E - II: Epidemiology, clinical manifestations, treatment and prevention. Expert Rev Gastroenterol Hepatol 2016;10:1065-74. [PMID: 27148907 DOI: 10.1080/17474124.2016.1185365] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
282 Passos-castilho AM, de Sena A, Domingues ALC, Lopes-neto EP, Medeiros TB, Granato CFH, Ferraz ML. Hepatitis E virus seroprevalence among schistosomiasis patients in Northeastern Brazil. The Brazilian Journal of Infectious Diseases 2016;20:262-6. [DOI: 10.1016/j.bjid.2016.03.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
283 Ricco G, Bonino F, Lanza M, Scatena F, Alfieri CM, Messa P, Marchisio E, Mascolo G, Romanò L, Galli C, Li TC, Wakita T, Miyamura T, Brunetto MR. New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: Prevalence in Italian blood donors and patients with chronic liver or kidney diseases. Dig Liver Dis 2016;48:536-41. [PMID: 26936342 DOI: 10.1016/j.dld.2016.01.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
284 Wang Y, Wang W, Xu L, Zhou X, Shokrollahi E, Felczak K, van der Laan LJ, Pankiewicz KW, Sprengers D, Raat NJ, Metselaar HJ, Peppelenbosch MP, Pan Q. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication. Antimicrob Agents Chemother 2016;60:2834-48. [PMID: 26926637 DOI: 10.1128/AAC.02700-15] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
285 Mallet V, van Bömmel F, Doerig C, Pischke S, Hermine O, Locasciulli A, Cordonnier C, Berg T, Moradpour D, Wedemeyer H, Ljungman P; ECIL-5. Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). Lancet Infect Dis 2016;16:606-17. [PMID: 27599653 DOI: 10.1016/S1473-3099(16)00118-3] [Cited by in Crossref: 96] [Cited by in F6Publishing: 102] [Article Influence: 13.7] [Reference Citation Analysis]
286 Kurihara T, Yoshizumi T, Itoh S, Harimoto N, Harada N, Ikegami T, Inagaki Y, Oshiro Y, Ohkohchi N, Okamoto H, Maehara Y. Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report. Surg Case Rep 2016;2:32. [PMID: 27059470 DOI: 10.1186/s40792-016-0159-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
287 Magnusson J, Norder H, Riise GC, Andersson LM, Brittain-Long R, Westin J. Incidence of Hepatitis E Antibodies in Swedish Lung Transplant Recipients. Transplant Proc. 2015;47:1972-1976. [PMID: 26293083 DOI: 10.1016/j.transproceed.2015.04.092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
288 Mansuy JM, Gallian P, Dimeglio C, Saune K, Arnaud C, Pelletier B, Morel P, Legrand D, Tiberghien P, Izopet J. A nationwide survey of hepatitis E viral infection in French blood donors. Hepatology 2016;63:1145-54. [PMID: 27008201 DOI: 10.1002/hep.28436] [Cited by in Crossref: 156] [Cited by in F6Publishing: 148] [Article Influence: 22.3] [Reference Citation Analysis]
289 Cartwright EJ, Wayne Wang YF. Viral Hepatitis. Manual of Commercial Methods in Clinical Microbiology 2016. [DOI: 10.1002/9781119021872.ch7] [Reference Citation Analysis]
290 Kamar N, Marion O, Abravanel F, Izopet J, Dalton HR. Extrahepatic manifestations of hepatitis E virus. Liver Int 2016;36:467-72. [PMID: 27005692 DOI: 10.1111/liv.13037] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 11.4] [Reference Citation Analysis]
291 Park WJ, Park BJ, Ahn HS, Lee JB, Park SY, Song CS, Lee SW, Yoo HS, Choi IS. Hepatitis E virus as an emerging zoonotic pathogen. J Vet Sci. 2016;17:1-11. [PMID: 27051334 DOI: 10.4142/jvs.2016.17.1.1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
292 Dalton HR, Kamar N, Izopet J. Hepatitis E Virus. Clinical Virology 2016. [DOI: 10.1128/9781555819439.ch50] [Reference Citation Analysis]
293 Abravanel F, Barragué H, Dörr G, Sauné K, Péron JM, Alric L, Kamar N, Izopet J, Champagne E. Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients. J Infect 2016;72:723-30. [PMID: 26947133 DOI: 10.1016/j.jinf.2016.02.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
294 Rathi S, Dhiman RK. Hepatobiliary Quiz Answers-17 (2016). J Clin Exp Hepatol 2016;6:73-6. [PMID: 27194902 DOI: 10.1016/j.jceh.2016.03.005] [Reference Citation Analysis]
295 Senosiain C, González-tallón A A, López-sanromán A, Mateos ML, Pérez-gracia MT, García-sánchez MC, Maroto M, Garrido E. Hepatitis E seroprevalence in inflammatory bowel disease. Gastroenterología y Hepatología 2016;39:185-90. [DOI: 10.1016/j.gastrohep.2015.06.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
296 Péron JM, Abravanel F, Guillaume M, Gérolami R, Nana J, Anty R, Pariente A, Renou C, Bureau C, Robic MA, Alric L, Vinel JP, Izopet J, Kamar N. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study. Liver Int 2016;36:328-33. [PMID: 26179015 DOI: 10.1111/liv.12911] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
297 Fierro NA, Realpe M, Meraz-Medina T, Roman S, Panduro A. Hepatitis E virus: An ancient hidden enemy in Latin America. World J Gastroenterol 2016; 22(7): 2271-2283 [PMID: 26900289 DOI: 10.3748/wjg.v22.i7.2271] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
298 Wang X, Li M, Li S, Wu T, Zhang J, Xia N, Zhao Q. Prophylaxis against hepatitis E: at risk populations and human vaccines. Expert Rev Vaccines. 2016;15:815-827. [PMID: 26775537 DOI: 10.1586/14760584.2016.1143365] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
299 Marion O, Abravanel F, Lhomme S, Izopet J, Kamar N. Hepatitis E in Transplantation. Curr Infect Dis Rep 2016;18. [DOI: 10.1007/s11908-016-0515-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
300 Khuroo MS, Khuroo MS. Hepatitis E: an emerging global disease - from discovery towards control and cure. J Viral Hepat 2016;23:68-79. [PMID: 26344932 DOI: 10.1111/jvh.12445] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 10.6] [Reference Citation Analysis]
301 Niesters HGM, Riezebos-brilman A, Van Leer-buter CC. Viral Hepatitis. Manual of Molecular and Clinical Laboratory Immunology 2016. [DOI: 10.1128/9781555818722.ch65] [Reference Citation Analysis]
302 Sue PK, Pisanic N, Heaney CD, Forman M, Valsamakis A, Jackson AM, Ticehurst JR, Montgomery RA, Schwarz KB, Nelson KE, Karnsakul W. Hepatitis E Virus Infection Among Solid Organ Transplant Recipients at a North American Transplant Center. Open Forum Infect Dis 2016;3:ofw006. [PMID: 27014710 DOI: 10.1093/ofid/ofw006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
303 Aggarwal A, Perumpail RB, Tummala S, Ahmed A. Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management. World J Hepatol 2016; 8(2): 117-122 [PMID: 26807207 DOI: 10.4254/wjh.v8.i2.117] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
304 Kamar N, Lhomme S, Abravanel F, Cointault O, Esposito L, Cardeau-Desangles I, Del Bello A, Dörr G, Lavayssière L, Nogier MB, Guitard J, Ribes D, Goin AL, Broué P, Metsu D, Sauné K, Rostaing L, Izopet J. An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients. Transplantation 2015;99:2124-31. [PMID: 26214817 DOI: 10.1097/TP.0000000000000850] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 7.9] [Reference Citation Analysis]
305 Egbewale BE, Mabayoje VO, Muhibi MA, Mustapha AF, Akinleye CA. Screening Outcomes of Hepatitis B and E among HIV Patients on HAART in Osogbo, South Western Nigeria. WJA 2016;06:205-217. [DOI: 10.4236/wja.2016.64023] [Reference Citation Analysis]
306 Nijskens CM, Pas SD, Cornelissen J, Caliskan K, Hoek RA, Hesselink DA, van der Eijk AA, de Man RA. Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity. Journal of Clinical Virology 2016;74:82-7. [DOI: 10.1016/j.jcv.2015.11.038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
307 Hui W, Wei L, Li Z, Guo X. Treatment of Hepatitis E. Adv Exp Med Biol 2016;948:211-21. [PMID: 27738987 DOI: 10.1007/978-94-024-0942-0_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
308 Michel RP, Marcus VA. Liver Transplantation. Pathology of Transplantation 2016. [DOI: 10.1007/978-3-319-29683-8_6] [Reference Citation Analysis]
309 Unzueta A, Valdez R, Chang YH, Desmarteau YM, Heilman RL, Scott RL, Douglas DD, Rakela J. Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation. Ann Hepatol 2016;15:33-40. [PMID: 26626638 DOI: 10.5604/16652681.1184202] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
310 Yurdaydin C. Immunohistochemistry for Viral Hepatitis: Methods and Applications. Biomarkers in Disease: Methods, Discoveries and Applications 2016. [DOI: 10.1007/978-94-007-7742-2_45-1] [Reference Citation Analysis]
311 Sue PK, Pisanic N, Heaney CD, Mixson-Hayden T, Kamili S, Nelson K, Schwarz KB, Forman M, Valsamakis A, Ticehurst J, Karnsakul W. Variability of hepatitis E serologic assays in a pediatric liver transplant recipient: challenges to diagnosing hepatitis E virus infection in the United States. Transpl Infect Dis 2015;17:284-8. [PMID: 25648626 DOI: 10.1111/tid.12366] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
312 Dalton HR, Kamar N, van Eijk JJ, Mclean BN, Cintas P, Bendall RP, Jacobs BC. Hepatitis E virus and neurological injury. Nat Rev Neurol. 2016;12:77-85. [PMID: 26711839 DOI: 10.1038/nrneurol.2015.234] [Cited by in Crossref: 154] [Cited by in F6Publishing: 158] [Article Influence: 19.3] [Reference Citation Analysis]
313 Peters van Ton AM, Gevers TJ, Drenth JP. Antiviral therapy in chronic hepatitis E: a systematic review. J Viral Hepat 2015;22:965-73. [PMID: 25760481 DOI: 10.1111/jvh.12403] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
314 Sayed IM, Vercouter AS, Abdelwahab SF, Vercauteren K, Meuleman P. Is hepatitis E virus an emerging problem in industrialized countries? Hepatology 2015;62:1883-92. [PMID: 26175182 DOI: 10.1002/hep.27990] [Cited by in Crossref: 83] [Cited by in F6Publishing: 82] [Article Influence: 10.4] [Reference Citation Analysis]
315 Lee GY, Poovorawan K, Intharasongkroh D, Sa-nguanmoo P, Vongpunsawad S, Chirathaworn C, Poovorawan Y. Hepatitis E virus infection: Epidemiology and treatment implications. World J Virology 2015; 4(4): 343-355 [PMID: 26568916 DOI: 10.5501/wjv.v4.i4.343] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
316 Kyvernitakis A, Taremi M, Blechacz B, Hwang J, Jiang Y, Mahale P, Torres HA. Impact of hepatitis E virus seropositivity on chronic liver disease in cancer patients with hepatitis C virus infection. Hepatol Res 2015;45:1146-51. [PMID: 25488194 DOI: 10.1111/hepr.12460] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
317 Lapa D, Capobianchi MR, Garbuglia AR. Epidemiology of Hepatitis E Virus in European Countries. Int J Mol Sci. 2015;16:25711-25743. [PMID: 26516843 DOI: 10.3390/ijms161025711] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 9.0] [Reference Citation Analysis]
318 Stramer SL, Moritz ED, Foster GA, Ong E, Linnen JM, Hogema BM, Mak M, Chia CP, Dodd RY. Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors: HEPATITIS E AMONG US BLOOD DONORS. Transfusion 2016;56:481-8. [DOI: 10.1111/trf.13355] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 8.4] [Reference Citation Analysis]
319 Vine LJ, Dalton HR. Hepatitis E, A and other hepatotropic viruses. Medicine 2015;43:594-598. [DOI: 10.1016/j.mpmed.2015.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
320 Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit. [Hepatitis E virus: opinions of the Working Group of the Federal Ministry of Health Blood]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2015;58:198-218. [PMID: 25608627 DOI: 10.1007/s00103-014-2103-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
321 Lhomme S, Abravanel F, Chapuy‐regaud S, Dubois M, Mansuy J, Peron J, Alric L, Rostaing L, Kamar N, Izopet J. Hepatitis E Virus. eLS 2015. [DOI: 10.1002/9780470015902.a0001030.pub3] [Reference Citation Analysis]
322 Wang Y, Metselaar HJ, Peppelenbosch MP, Pan Q. Chronic hepatitis E in solid-organ transplantation: the key implications of immunosuppressants. Curr Opin Infect Dis. 2014;27:303-308. [PMID: 24977682 DOI: 10.1097/qco.0000000000000074] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
323 van der Eijk AA, Pas SD, Cornelissen JJ, de Man RA. Hepatitis E virus infection in hematopoietic stem cell transplant recipients. Curr Opin Infect Dis. 2014;27:309-315. [PMID: 24977683 DOI: 10.1097/qco.0000000000000076] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
324 Murali AR, Kotwal V, Chawla S. Chronic hepatitis E: A brief review. World J Hepatol 2015; 7(19): 2194-2201 [PMID: 26380044 DOI: 10.4254/wjh.v7.i19.2194] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
325 Koning L, Charlton MR, Pas SD, Heimbach JK, Osterhaus AD, Watt KD, Janssen HL, de Knegt RJ, van der Eijk AA. Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States. BMC Infect Dis. 2015;15:371. [PMID: 26328802 DOI: 10.1186/s12879-015-1103-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
326 Waldenström J, Castedal M, Konar J, Karason K, Lagging M, Norder H. Chronic hepatitis E infection with an emerging virus strain in a heart transplant recipient successfully treated with ribavirin: a case report. J Med Case Rep 2015;9:180. [PMID: 26307049 DOI: 10.1186/s13256-015-0655-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
327 Passos-castilho AM, de Sena A, Geraldo A, Spada C, Granato CF. High prevalence of hepatitis E virus antibodies among blood donors in Southern Brazil: High Prevalence of Hepatitis E Virus in Brazil. J Med Virol 2016;88:361-4. [DOI: 10.1002/jmv.24336] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
328 Dalton HR, Kamar N, Izopet J. Hepatitis E in developed countries: current status and future perspectives. Future Microbiol. 2014;9:1361-1372. [PMID: 25517900 DOI: 10.2217/fmb.14.89] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
329 Laverdure N, Scholtès-brunel C, Rivet C, Heissat S, Restier L, Bacchetta J, Boillot O, Dumortier J, Lachaux A. Paediatric liver transplanted patients and prevalence of hepatitis E virus. Journal of Clinical Virology 2015;69:22-6. [DOI: 10.1016/j.jcv.2015.04.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
330 Kotton CN. Taming the Beast: Tailored Therapy for Hepatitis E in Organ Transplant Recipients. Transplantation 2015;99:2020-1. [PMID: 26214818 DOI: 10.1097/TP.0000000000000849] [Reference Citation Analysis]
331 Galante A, Pischke S, Polywka S, Luetgehethmann M, Suneetha PV, Gisa A, Hiller J, Dienes HP, Nashan B, Lohse AW, Sterneck M. Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting. Transpl Infect Dis. 2015;17:617-622. [PMID: 26094550 DOI: 10.1111/tid.12411] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
332 Pischke S, Behrendt P, Bock CT, Jilg W, Manns MP, Wedemeyer H. Hepatitis E in Germany--an under-reported infectious disease. Dtsch Arztebl Int 2014;111:577-83. [PMID: 25249359 DOI: 10.3238/arztebl.2014.0577] [Cited by in Crossref: 15] [Cited by in F6Publishing: 41] [Article Influence: 1.9] [Reference Citation Analysis]
333 Yazbek S, Kreidieh K, Ramia S. Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety. Infection. 2016;44:11-22. [PMID: 26112744 DOI: 10.1007/s15010-015-0807-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
334 Passos-castilho AM, Sena AD, Reinaldo MR, Granato CFH. Hepatitis E virus infection in Brazil: results of laboratory-based surveillance from 1998 to 2013. Rev Soc Bras Med Trop 2015;48:468-70. [DOI: 10.1590/0037-8682-0036-2015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
335 Andersson MI, Stead PA, Maponga T, van der Plas H, Preiser W. Hepatitis E virus infection: An underdiagnosed infection in transplant patients in Southern Africa? J Clin Virol. 2015;70:23-25. [PMID: 26305814 DOI: 10.1016/j.jcv.2015.06.081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
336 Kenney SP, Meng XJ. Therapeutic targets for the treatment of hepatitis E virus infection. Expert Opin Ther Targets 2015;19:1245-60. [PMID: 26073772 DOI: 10.1517/14728222.2015.1056155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
337 Salines M, Barnaud E, Andraud M, Eono F, Renson P, Bourry O, Pavio N, Rose N. Hepatitis E virus chronic infection of swine co-infected with Porcine Reproductive and Respiratory Syndrome Virus. Vet Res 2015;46:55. [PMID: 26048774 DOI: 10.1186/s13567-015-0207-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
338 Pauli G, Aepfelbacher M, Bauerfeind U, Blümel J, Burger R, Gärtner B, Gröner A, Gürtler L, Heiden M, Hildebrandt M, Jansen B, Offergeld R, Schlenkrich U, Schottstedt V, Seitz R, Strobel J, Willkommen H, Baylis SA; German Advisory Committee Blood (Arbeitskreis Blut), Subgroup ‘Assessment of Pathogens Transmissible by Blood’. Hepatitis E Virus. Transfus Med Hemother 2015;42:247-65. [PMID: 26557817 DOI: 10.1159/000431191] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
339 Viral Zoonoses. Zoonoses 2015. [DOI: 10.1128/9781555819262.ch1] [Reference Citation Analysis]
340 Ramezani A, Mohraz M, Banifazl M, Aghakhani A. Significance of hepatitis E virus infection in HIV-infected patients: a challenging issue. Asian Pacific Journal of Tropical Disease 2015;5:337-341. [DOI: 10.1016/s2222-1808(14)60794-5] [Reference Citation Analysis]
341 Prpić J, Černi S, Škorić D, Keros T, Brnić D, Cvetnić Ž, Jemeršić L. Distribution and Molecular Characterization of Hepatitis E virus in Domestic Animals and Wildlife in Croatia. Food Environ Virol 2015;7:195-205. [PMID: 25820413 DOI: 10.1007/s12560-015-9193-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
342 Sridhar S, Lau SK, Woo PC. Hepatitis E: A disease of reemerging importance. J Formos Med Assoc. 2015;114:681-690. [PMID: 25773541 DOI: 10.1016/j.jfma.2015.02.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
343 Speers DJ, Ma MX, Faddy HM, Nash M, Bowden S, Boer B, Macnicholas R, Macquillan G, Adams L. Domestically acquired hepatitis E successfully treated with ribavirin in an Australian liver transplant recipient. Medical Journal of Australia 2015;202:209-11. [DOI: 10.5694/mja14.00453] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
344 Riveiro-Barciela M, Mínguez B, Gironés R, Rodriguez-Frías F, Quer J, Buti M. Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion. J Clin Gastroenterol 2015;49:165-8. [PMID: 24637729 DOI: 10.1097/MCG.0000000000000113] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 8.5] [Reference Citation Analysis]
345 Lens S, Mensa L, Gambato M, González P, Torras X, Soriano G, Costa J, Capón A, Londoño M, Mariño Z, Navasa M, Pérez-del-pulgar S, Forns X. HEV infection in two referral centers in Spain; epidemiology and clinical outcomes. Journal of Clinical Virology 2015;63:76-80. [DOI: 10.1016/j.jcv.2014.12.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
346 Kamar N, Abravanel F, Lhomme S, Rostaing L, Izopet J. Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Clin Res Hepatol Gastroenterol 2015;39:20-7. [PMID: 25150374 DOI: 10.1016/j.clinre.2014.07.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 8.3] [Reference Citation Analysis]
347 Kamar N, Rostaing L, Alric L, Peron JM, Izopet J. [Treatment of hepatitis E virus infection]. Presse Med 2015;44:339-42. [PMID: 25639626 DOI: 10.1016/j.lpm.2014.10.011] [Reference Citation Analysis]
348 Kenney SP, Meng XJ. The lysine residues within the human ribosomal protein S17 sequence naturally inserted into the viral nonstructural protein of a unique strain of hepatitis E virus are important for enhanced virus replication. J Virol. 2015;89:3793-3803. [PMID: 25609799 DOI: 10.1128/jvi.03582-14] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
349 Demetris AJ, Minervini MI, Nalesnik MA, Randhawa P, Sasatomi E. Histopathology of Liver Transplantation. Transplantation of the Liver 2015. [DOI: 10.1016/b978-1-4557-0268-8.00084-1] [Reference Citation Analysis]
350 Walsh SR. Hepatitis E Virus. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2015. [DOI: 10.1016/b978-1-4557-4801-3.00180-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
351 Dalton HR, Izopet J, Banks M, Bendall R, Kamar N. Hepatitis E: The Commonest Viral Zoonosis Worldwide? Zoonoses - Infections Affecting Humans and Animals 2015. [DOI: 10.1007/978-94-017-9457-2_37] [Reference Citation Analysis]
352 Dienstag JL, Delemos AS. Viral Hepatitis. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2015. [DOI: 10.1016/b978-1-4557-4801-3.00119-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
353 Dalton HR, Saunders M, Woolson KL. Hepatitis E virus in developed countries: one of the most successful zoonotic viral diseases in human history? Journal of Virus Eradication 2015;1:23-9. [DOI: 10.1016/s2055-6640(20)31147-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
354 Jeong SW, Choi Y, Kim JW. Management of viral hepatitis in liver transplant recipients. Clin Mol Hepatol. 2014;20:338-344. [PMID: 25548738 DOI: 10.3350/cmh.2014.20.4.338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
355 Hesselink DA, Weimar W. Renal transplantation in 2014: renal transplantation-reducing risk and improving outcome. Nat Rev Nephrol 2015;11:72-3. [PMID: 25511759 DOI: 10.1038/nrneph.2014.240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
356 Behrendt P, Steinmann E, Manns MP, Wedemeyer H. The impact of hepatitis E in the liver transplant setting. J Hepatol 2014;61:1418-29. [PMID: 25195557 DOI: 10.1016/j.jhep.2014.08.047] [Cited by in Crossref: 98] [Cited by in F6Publishing: 94] [Article Influence: 10.9] [Reference Citation Analysis]
357 Protzer U, Böhm F, Longerich T, Seebach J, Heidary Navid M, Friemel J, Marques-Maggio E, Bawohl M, Heikenwalder M, Schirmacher P, Dutkowski P, Clavien PA, Schemmer P, Schnitzler P, Gotthardt D, Müllhaupt B, Weber A. Molecular detection of hepatitis E virus (HEV) in liver biopsies after liver transplantation. Mod Pathol 2015;28:523-32. [PMID: 25412844 DOI: 10.1038/modpathol.2014.147] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
358 Kmush BL, Nelson KE, Labrique AB. Risk factors for hepatitis E virus infection and disease. Expert Review of Anti-infective Therapy 2014;13:41-53. [DOI: 10.1586/14787210.2015.981158] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
359 Munjal S, Gupta N, Sharma RK, Gupta A, Prasad N, Kaul A, Bhadauria D, Goel A, Aggarwal R. Lack of persistent hepatitis E virus infection as a cause for unexplained transaminase elevation in renal transplant recipients in India. Indian J Gastroenterol 2014;33:550-3. [PMID: 25266354 DOI: 10.1007/s12664-014-0508-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
360 Pawlotsky J. Hepatitis E screening for blood donations: an urgent need? The Lancet 2014;384:1729-30. [DOI: 10.1016/s0140-6736(14)61187-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
361 Debing Y, Gisa A, Dallmeier K, Pischke S, Bremer B, Manns M, Wedemeyer H, Suneetha PV, Neyts J. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology 2014;147:1008-11.e7; quiz e15-6. [PMID: 25181691 DOI: 10.1053/j.gastro.2014.08.040] [Cited by in Crossref: 150] [Cited by in F6Publishing: 149] [Article Influence: 16.7] [Reference Citation Analysis]
362 Vassallo D, Husain MM, Greer S, McGrath S, Ijaz S, Kanigicherla D. Hepatitis e infection in a renal transplant recipient. Case Rep Nephrol 2014;2014:865471. [PMID: 25295201 DOI: 10.1155/2014/865471] [Reference Citation Analysis]
363 Debing Y, Neyts J. mTOR-inhibitors may aggravate chronic hepatitis E. J Hepatol 2014;61:720-2. [PMID: 25046849 DOI: 10.1016/j.jhep.2014.07.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
364 Passos-Castilho AM, Porta G, Miura IK, Pugliese RP, Danesi VL, Porta A, Guimarães T, Seda J, Antunes E, Granato CF. Chronic hepatitis E virus infection in a pediatric female liver transplant recipient. J Clin Microbiol 2014;52:4425-7. [PMID: 25275004 DOI: 10.1128/JCM.02286-14] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
365 Fishman JA, Grossi PA. Donor-derived infection--the challenge for transplant safety. Nat Rev Nephrol. 2014;10:663-672. [PMID: 25178971 DOI: 10.1038/nrneph.2014.159] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
366 Verna EC. Hepatitis viruses and liver transplantation: evolving trends in antiviral management. Clin Liver Dis 2014;18:575-601. [PMID: 25017077 DOI: 10.1016/j.cld.2014.05.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
367 Stramer SL. Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. ISBT Sci Ser 2014;9:30-6. [PMID: 25210533 DOI: 10.1111/voxs.12070] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 7.9] [Reference Citation Analysis]
368 Demetris AJ, Minervini MI, Nalesnik MA, Rubin E, Randhawa P, Sasatomi E. Histopathological Syndromes of Liver Allograft Rejection and Recurrent Disease. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch82] [Reference Citation Analysis]
369 Malinnikova EY, Ilchenko LY, Mikhaylov MI. VIRAL HEPATITIS E DIAGNOSTICS. Russian Journal of Infection and Immunity 2014;3:379-384. [DOI: 10.15789/2220-7619-2013-4-379-384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
370 Kamar N, Izopet J. Does chronic hepatitis E virus infection exist in immunocompetent patients? Hepatology 2014;60:427. [PMID: 24214924 DOI: 10.1002/hep.26927] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
371 Soriano V, Barreiro P. Hepatitis E: una enfermedad viral emergente. Medicina Clínica 2014;143:22-4. [DOI: 10.1016/j.medcli.2014.01.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
372 Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27:116-138. [PMID: 24396139 DOI: 10.1128/cmr.00057-13] [Cited by in Crossref: 410] [Cited by in F6Publishing: 429] [Article Influence: 45.6] [Reference Citation Analysis]
373 Krain LJ, Nelson KE, Labrique AB. Host immune status and response to hepatitis E virus infection. Clin Microbiol Rev 2014;27:139-65. [PMID: 24396140 DOI: 10.1128/CMR.00062-13] [Cited by in Crossref: 101] [Cited by in F6Publishing: 114] [Article Influence: 11.2] [Reference Citation Analysis]
374 Mirazo S, Ramos N, Mainardi V, Gerona S, Arbiza J. Transmission, diagnosis, and management of hepatitis E: an update. Hepat Med. 2014;6:45-59. [PMID: 24966702 DOI: 10.2147/hmer.s63417] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 8.7] [Reference Citation Analysis]
375 Wang Y, Zhou X, Debing Y, Chen K, Van Der Laan LJ, Neyts J, Janssen HL, Metselaar HJ, Peppelenbosch MP, Pan Q. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus. Gastroenterology 2014;146:1775-83. [PMID: 24582714 DOI: 10.1053/j.gastro.2014.02.036] [Cited by in Crossref: 131] [Cited by in F6Publishing: 133] [Article Influence: 14.6] [Reference Citation Analysis]
376 Aderinto-Adike A, Schwartz MR, Monsour HP Jr. Acute Hepatitis E in the US Today Occurs in Diverse Patient Populations: Case Reports. Gastroenterology Res 2014;7:69-72. [PMID: 27785273 DOI: 10.14740/gr602e] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
377 Tischer S, Fontana RJ. Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting. J Hepatol 2014;60:872-84. [PMID: 24280292 DOI: 10.1016/j.jhep.2013.11.013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
378 Nelson KE. Transmission of hepatitis E virus by transfusion: what is the risk? Transfusion 2014;54:8-10. [PMID: 24405304 DOI: 10.1111/trf.12504] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
379 Dalton HR, Pas SD, Madden RG, van der Eijk AA. Hepatitis e virus: current concepts and future perspectives. Curr Infect Dis Rep. 2014;16:399. [PMID: 24585215 DOI: 10.1007/s11908-014-0399-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
380 Rosenthal P. Hepatitis A and hepatitis E virus infection. Liver Disease in Children 2014. [DOI: 10.1017/cbo9781139012102.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
381 Buffaz C, Scholtes C, Dron AG, Chevallier-Queyron P, Ritter J, André P, Ramière C. Hepatitis E in liver transplant recipients in the Rhône-Alpes region in France. Eur J Clin Microbiol Infect Dis 2014;33:1037-43. [PMID: 24445407 DOI: 10.1007/s10096-013-2042-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
382 Pischke S, Greer M, Hardtke S, Bremer B, Gisa A, Lehmann P, Haverich A, Welte T, Manns MP, Wedemeyer H, Gottlieb J;  Hepatitis E study group. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients. Transpl Infect Dis. 2014;16:333-339. [PMID: 24438577 DOI: 10.1111/tid.12183] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
383 Abravanel F, Lhomme S, Chapuy-Regaud S, Mansuy JM, Muscari F, Sallusto F, Rostaing L, Kamar N, Izopet J. Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections. J Infect Dis. 2014;209:1900-1906. [PMID: 24436450 DOI: 10.1093/infdis/jiu032] [Cited by in Crossref: 114] [Cited by in F6Publishing: 115] [Article Influence: 12.7] [Reference Citation Analysis]
384 Krain LJ, Atwell JE, Nelson KE, Labrique AB. Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infection. Am J Trop Med Hyg 2014;90:365-70. [PMID: 24420778 DOI: 10.4269/ajtmh.13-0265] [Cited by in Crossref: 56] [Cited by in F6Publishing: 62] [Article Influence: 6.2] [Reference Citation Analysis]
385 Shetty S, Adams DH, Hubscher SG. Post-transplant liver biopsy and the immune response: lessons for the clinician. Expert Review of Clinical Immunology 2014;8:645-61. [DOI: 10.1586/eci.12.65] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
386 Moal V, Motte A, Kaba M, Gerolami R, Berland Y, Colson P. Hepatitis E virus serological testing in kidney transplant recipients with elevated liver enzymes in 2007-2011 in southeastern France. Diagn Microbiol Infect Dis. 2013;76:116-118. [PMID: 23608351 DOI: 10.1016/j.diagmicrobio.2013.02.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
387 Takahashi H, Zeniya M. Hepatitis E. Liver Immunology 2014. [DOI: 10.1007/978-3-319-02096-9_17] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
388 Unzueta A, Rakela J. Hepatitis E infection in liver transplant recipients. Liver Transpl 2014;20:15-24. [PMID: 24123928 DOI: 10.1002/lt.23764] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
389 Debing Y, Neyts J. Antiviral strategies for hepatitis E virus. Antiviral Res 2014;102:106-18. [PMID: 24374149 DOI: 10.1016/j.antiviral.2013.12.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
390 Samala N, Ghany MG. Hepatitis E: The nonendemic perspective. Clin Liver Dis (Hoboken) 2013;2:245-9. [PMID: 30992873 DOI: 10.1002/cld.256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
391 Arends JE, Ghisetti V, Irving W, Dalton HR, Izopet J, Hoepelman AI, Salmon D. Hepatitis E: An emerging infection in high income countries. J Clin Virol. 2014;59:81-88. [PMID: 24388207 DOI: 10.1016/j.jcv.2013.11.013] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 6.6] [Reference Citation Analysis]
392 Agrawal S, Dhiman RK. Hepatobiliary quiz-8 (2013). J Clin Exp Hepatol 2013;3:357-61. [PMID: 25755526 DOI: 10.1016/j.jceh.2013.11.002] [Reference Citation Analysis]
393 Feng Z, Lemon SM. Peek-a-boo: membrane hijacking and the pathogenesis of viral hepatitis. Trends Microbiol 2014;22:59-64. [PMID: 24268716 DOI: 10.1016/j.tim.2013.10.005] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 6.7] [Reference Citation Analysis]
394 Zhou Y, Geng Y, Yang J, Zhao C, Harrison TJ, Wang Y. Hepatitis E virus open reading frame 3 protein interacts with porcine liver-specific plasminogen and α2-antiplasmin: Interactions Between HEV ORF3 and Cell Proteins. J Med Virol 2014;86:487-95. [DOI: 10.1002/jmv.23800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
395 Huang SJ, Liu XH, Zhang J, Ng MH. Protective immunity against HEV. Curr Opin Virol. 2014;5:1-6. [PMID: 24835679 DOI: 10.1016/j.coviro.2013.10.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
396 Debing Y, Emerson SU, Wang Y, Pan Q, Balzarini J, Dallmeier K, Neyts J. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon. Antimicrob Agents Chemother 2014;58:267-73. [PMID: 24145541 DOI: 10.1128/AAC.01795-13] [Cited by in Crossref: 109] [Cited by in F6Publishing: 110] [Article Influence: 10.9] [Reference Citation Analysis]
397 Pavio N, Bouquet J. ZOONOTIC HEPATITIS E. Viral Infections and Global Change 2013. [DOI: 10.1002/9781118297469.ch24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
398 Mateos-Lindemann ML, Diez-Aguilar M, Galdamez AL, Galán JC, Moreno A, Pérez-Gracia MT. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain. J Med Virol 2014;86:71-4. [PMID: 24136591 DOI: 10.1002/jmv.23804] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
399 Kimura Y, Gotoh A, Katagiri S, Hoshi Y, Uchida S, Yamasaki A, Takahashi Y, Fukutake K, Kiguchi T, Ohyashiki K. Transfusion-transmitted hepatitis E in a patient with myelodysplastic syndromes. Blood Transfus. 2014;12:103-106. [PMID: 24120594 DOI: 10.2450/2013.0081-13] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
400 Riezebos-Brilman A, Verschuuren EA, van Son WJ, van Imhoff GW, Brügemann J, Blokzijl H, Niesters HG. The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5-year period. J Clin Virol 2013;58:509-14. [PMID: 24055152 DOI: 10.1016/j.jcv.2013.08.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
401 Agrawal S, Dhiman RK. Hepatobiliary quiz-7 (2013). J Clin Exp Hepatol 2013;3:267-71. [PMID: 25755512 DOI: 10.1016/j.jceh.2013.08.006] [Reference Citation Analysis]
402 Pérez-Gracia MT, Mateos Lindemann ML, Caridad Montalvo Villalba M. Hepatitis E: current status. Rev Med Virol 2013;23:384-98. [PMID: 24038432 DOI: 10.1002/rmv.1759] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
403 Stramer SL, Dodd RY; AABB Transfusion-Transmitted Diseases Emerging Infectious Diseases Subgroup. Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress. Transfusion 2013;53:2375-83. [PMID: 23926897 DOI: 10.1111/trf.12371] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 5.8] [Reference Citation Analysis]
404 Kelly DA, Bucuvalas JC, Alonso EM, Karpen SJ, Allen U, Green M, Farmer D, Shemesh E, McDonald RA; American Association for the Study of Liver Diseases, American Society of Transplantation. Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013;19:798-825. [PMID: 23836431 DOI: 10.1002/lt.23697] [Cited by in Crossref: 117] [Cited by in F6Publishing: 102] [Article Influence: 11.7] [Reference Citation Analysis]
405 Maddukuri VC, Russo MW, Ahrens WA, Emerson SU, Engle RE, Purcell RH, Thompson EB, Bonkovsky HL. Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient. Dig Dis Sci 2013;58:2413-6. [PMID: 23512404 DOI: 10.1007/s10620-013-2628-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
406 Slot E, Hogema BM, Riezebos-Brilman A, Kok TM, Molier M, Zaaijer HL. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013;18:20550. [PMID: 23929229 DOI: 10.2807/1560-7917.es2013.18.31.20550] [Cited by in Crossref: 138] [Cited by in F6Publishing: 154] [Article Influence: 13.8] [Reference Citation Analysis]
407 Coilly A, Haïm-boukobza S, Roche B, Antonini TM, Pause A, Mokhtari C, Becq A, Farahmand H, Hauser L, Duclos-vallée J, Samuel D, Adam R, Roque-afonso A. Posttransplantation Hepatitis E: Transfusion-Transmitted Hepatitis Rising from the Ashes. Transplantation 2013;96:e4-6. [DOI: 10.1097/tp.0b013e318296c9f7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
408 Lin CL, Xu CQ, Wands JR. Clinical and Diagnostic Aspects of Viral Hepatitis. Viral Hepatitis 2013. [DOI: 10.1002/9781118637272.ch33] [Reference Citation Analysis]
409 Cyril S, Cramp ME. Clinical and Pathological Features, and Diagnosis. Viral Hepatitis 2013. [DOI: 10.1002/9781118637272.ch32] [Reference Citation Analysis]
410 Demetris AJ, Isse K. Tissue biopsy monitoring of operational tolerance in liver allograft recipients. Curr Opin Organ Transplant 2013;18:345-53. [PMID: 23619515 DOI: 10.1097/MOT.0b013e3283615d48] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
411 Waggoner JJ, Soda EA, Deresinski S. Rare and emerging viral infections in transplant recipients. Clin Infect Dis. 2013;57:1182-1188. [PMID: 23839998 DOI: 10.1093/cid/cit456] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
412 Zhou X, de Man RA, de Knegt RJ, Metselaar HJ, Peppelenbosch MP, Pan Q. Epidemiology and management of chronic hepatitis E infection in solid organ transplantation: a comprehensive literature review. Rev Med Virol. 2013;23:295-304. [PMID: 23813631 DOI: 10.1002/rmv.1751] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
413 Abravanel F, Lhomme S, Dubois M, Peron J, Alric L, Kamar N, Izopet J. Hepatitis E virus. Médecine et Maladies Infectieuses 2013;43:263-70. [DOI: 10.1016/j.medmal.2013.03.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
414 Versluis J, Pas SD, Agteresch HJ, de Man RA, Maaskant J, Schipper ME, Osterhaus AD, Cornelissen JJ, van der Eijk AA. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood. 2013;122:1079-1086. [PMID: 23794068 DOI: 10.1182/blood-2013-03-492363] [Cited by in Crossref: 98] [Cited by in F6Publishing: 102] [Article Influence: 9.8] [Reference Citation Analysis]
415 Cleland A, Smith L, Crossan C, Blatchford O, Dalton HR, Scobie L, Petrik J. Hepatitis E virus in Scottish blood donors. Vox Sang. 2013;105:283-289. [PMID: 23763589 DOI: 10.1111/vox.12056] [Cited by in Crossref: 104] [Cited by in F6Publishing: 106] [Article Influence: 10.4] [Reference Citation Analysis]
416 Sclair SN, Schiff ER. An update on the hepatitis E virus. Curr Gastroenterol Rep. 2013;15:304. [PMID: 23314803 DOI: 10.1007/s11894-012-0304-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
417 Feldt T, Sarfo FS, Zoufaly A, Phillips RO, Burchard G, van Lunzen J, Jochum J, Chadwick D, Awasom C, Claussen L, Drosten C, Drexler JF, Eis-Hübinger AM. Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon. J Clin Virol 2013;58:18-23. [PMID: 23743346 DOI: 10.1016/j.jcv.2013.05.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
418 Koning L, Pas SD, de Man RA, Balk AH, de Knegt RJ, ten Kate FJ, Osterhaus AD, van der Eijk AA. Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. J Heart Lung Transplant. 2013;32:78-85. [PMID: 23260707 DOI: 10.1016/j.healun.2012.10.008] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
419 Kamar N, Izopet J, Dalton HR. Chronic hepatitis e virus infection and treatment. J Clin Exp Hepatol 2013;3:134-40. [PMID: 25755487 DOI: 10.1016/j.jceh.2013.05.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
420 Naini BV, Lassman CR. Liver Transplant Pathology: Review of Challenging Diagnostic Situations. Surg Pathol Clin 2013;6:277-93. [PMID: 26838975 DOI: 10.1016/j.path.2013.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
421 Pischke S, Wedemeyer H. Hepatitis E virus infection: multiple faces of an underestimated problem. J Hepatol 2013;58:1045-6. [PMID: 23266489 DOI: 10.1016/j.jhep.2012.12.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
422 Kamar N, Izopet J, Rostaing L. Hepatitis E virus infection. Curr Opin Gastroenterol 2013;29:271-8. [PMID: 23507918 DOI: 10.1097/MOG.0b013e32835ff238] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
423 Kumar N, Sarin SK. Hepatitis E- Is it a risk to transfusion safety? Asian J Transfus Sci 2013;7:1-3. [PMID: 23559753 DOI: 10.4103/0973-6247.106708] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
424 Debing Y, Jochmans D, Neyts J. Intervention strategies for emerging viruses: use of antivirals. Curr Opin Virol 2013;3:217-24. [PMID: 23562753 DOI: 10.1016/j.coviro.2013.03.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
425 Naik A, Gupta N, Goel D, Ippagunta SK, Sharma RK, Aggarwal R. Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area. J Viral Hepat 2013;20:e138-40. [PMID: 23490383 DOI: 10.1111/jvh.12027] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
426 Levitsky J, Doucette K; AST Infectious Diseases Community of Practice. Viral hepatitis in solid organ transplantation. Am J Transplant 2013;13 Suppl 4:147-68. [PMID: 23465008 DOI: 10.1111/ajt.12108] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 6.0] [Reference Citation Analysis]
427 Passos AM, Heringer TP, Medina-pestana JO, Ferraz MLG, Granato CFH. First report and molecular characterization of hepatitis E virus infection in renal transplant recipients in Brazil. J Med Virol 2013;85:615-9. [DOI: 10.1002/jmv.23494] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
428 Pas SD, de Man RA, Mulders C, Balk AH, van Hal PT, Weimar W, Koopmans MP, Osterhaus AD, van der Eijk AA. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis. 2012;18:869-872. [PMID: 22516170 DOI: 10.3201/eid1805.111712] [Cited by in Crossref: 116] [Cited by in F6Publishing: 118] [Article Influence: 11.6] [Reference Citation Analysis]
429 Scobie L, Dalton HR. Hepatitis E: source and route of infection, clinical manifestations and new developments. J Viral Hepat 2013;20:1-11. [PMID: 23231079 DOI: 10.1111/jvh.12024] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 6.9] [Reference Citation Analysis]
430 Boettler T, Blum HE, Thimme R. Virushepatitis A und E. Gastroenterologe 2013;8:14-19. [DOI: 10.1007/s11377-012-0692-8] [Reference Citation Analysis]
431 雷 雅. Development of Genomic Structure and Function of Hepatitis E Virus. AMB 2013;02:32-36. [DOI: 10.12677/amb.2013.21007] [Reference Citation Analysis]
432 Tan LT, Tan J, Ang LW, Chan KP, Chiew KT, Cutter J, Chew SK, Goh KT. Epidemiology of acute hepatitis E in Singapore. J Infect. 2013;66:453-459. [PMID: 23286967 DOI: 10.1016/j.jinf.2012.11.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
433 Borkakoti J, Hazam RK, Mohammad A, Kumar A, Kar P. Does high viral load of hepatitis E virus influence the severity and prognosis of acute liver failure during pregnancy? J Med Virol. 2013;85:620-626. [PMID: 23280991 DOI: 10.1002/jmv.23508] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
434 Moal V, Legris T, Burtey S, Morange S, Purgus R, Dussol B, Garcia S, Motte A, Gérolami R, Berland Y. Infection with hepatitis E virus in kidney transplant recipients in southeastern France. J Med Virol. 2013;85:462-471. [PMID: 23239466 DOI: 10.1002/jmv.23469] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
435 Harrison A, Scobie L, Crossan C, Parry R, Johnston P, Stratton J, Dickinson S, Ellis V, Hunter JG, Prescott OR. Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study. J Med Virol. 2013;85:266-271. [PMID: 23169048 DOI: 10.1002/jmv.23463] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
436 Zhao Q, Zhang J, Wu T, Li SW, Ng MH, Xia NS, Shih JW. Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy. J Gastroenterol. 2013;48:159-168. [PMID: 23149436 DOI: 10.1007/s00535-012-0701-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
437 Moal V, Zandotti C, Colson P. Emerging viral diseases in kidney transplant recipients. Rev Med Virol 2013;23:50-69. [PMID: 23132728 DOI: 10.1002/rmv.1732] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
438 Angelico M. Unexplained hepatic deterioration--keep in mind hepatitis E virus infection! Dig Liver Dis 2012;44:895-6. [PMID: 22985789 DOI: 10.1016/j.dld.2012.08.024] [Reference Citation Analysis]
439 De Silva S, Hassan-Ibrahim MO, Austin M, Newport M, Verma S. Hepatitis E infection is an under recognized cause of acute decompensation in patients with chronic liver disease. Dig Liver Dis 2012;44:930-4. [PMID: 22592074 DOI: 10.1016/j.dld.2012.04.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
440 Pischke S, Stiefel P, Franz B, Bremer B, Suneetha PV, Heim A, Ganzenmueller T, Schlue J, Horn-Wichmann R, Raupach R, Darnedde M, Scheibner Y, Taubert R, Haverich A, Manns MP, Wedemeyer H, Bara CL. Chronic hepatitis e in heart transplant recipients. Am J Transplant 2012;12:3128-33. [PMID: 22823202 DOI: 10.1111/j.1600-6143.2012.04200.x] [Cited by in Crossref: 124] [Cited by in F6Publishing: 126] [Article Influence: 11.3] [Reference Citation Analysis]
441 Rossi-Tamisier M, Moal V, Gerolami R, Colson P. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. J Clin Virol. 2013;56:62-64. [PMID: 23089569 DOI: 10.1016/j.jcv.2012.09.010] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 4.6] [Reference Citation Analysis]
442 Moal V, Textoris J, Ben Amara A, Mehraj V, Berland Y, Colson P, Mege JL. Chronic hepatitis E virus infection is specifically associated with an interferon-related transcriptional program. J Infect Dis 2013;207:125-32. [PMID: 23072754 DOI: 10.1093/infdis/jis632] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
443 Kaltsas A, Sepkowitz K. Community acquired respiratory and gastrointestinal viral infections: challenges in the immunocompromised host. Curr Opin Infect Dis. 2012;25:423-430. [PMID: 22766648 DOI: 10.1097/qco.0b013e328355660b] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 3.7] [Reference Citation Analysis]
444 Banff Working Group on Liver Allograft Pathology. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. Liver Transpl 2012;18:1154-70. [PMID: 22645090 DOI: 10.1002/lt.23481] [Cited by in Crossref: 98] [Cited by in F6Publishing: 84] [Article Influence: 8.9] [Reference Citation Analysis]
445 Moal V, Legris T, Burtey S, Morange S, Purgus R, Dussol B, Garcia S, Motte A, Gérolami R, Berland Y, Colson P. Caractéristiques et devenir des infections par le virus de l’hépatite E dans une cohorte de transplantés rénaux. Néphrologie & Thérapeutique 2012;8:285-286. [DOI: 10.1016/j.nephro.2012.07.339] [Reference Citation Analysis]
446 Kamar N, Legrand-Abravanel F, Izopet J, Rostaing L. Hepatitis E virus: what transplant physicians should know. Am J Transplant 2012;12:2281-7. [PMID: 22549004 DOI: 10.1111/j.1600-6143.2012.04078.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
447 Bonnet D, Kamar N, Izopet J, Alric L. L’hépatite virale E : une maladie émergente. La Revue de Médecine Interne 2012;33:328-34. [DOI: 10.1016/j.revmed.2012.01.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
448 Riveiro-Barciela M, Rodríguez-Frías F, Buti M. [Hepatitis E: scale of the problem in Spain]. Gastroenterol Hepatol 2012;35:719-24. [PMID: 22608490 DOI: 10.1016/j.gastrohep.2012.03.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
449 Kamar N, Weclawiak H, Guilbeau-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D, Esposito L, Cardeau-Desangles I, Guitard J, Sallusto F, Muscari F, Peron JM, Alric L, Izopet J, Rostaing L. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation. 2012;93:617-623. [PMID: 22298032 DOI: 10.1097/tp.0b013e318245f14c] [Cited by in Crossref: 147] [Cited by in F6Publishing: 152] [Article Influence: 13.4] [Reference Citation Analysis]
450 Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis e virus infection. Gastroenterology 2012;142:1388-1397.e1. [PMID: 22537448 DOI: 10.1053/j.gastro.2012.02.014] [Cited by in Crossref: 226] [Cited by in F6Publishing: 232] [Article Influence: 20.5] [Reference Citation Analysis]
451 Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Hepatitis E. Lancet. 2012;379:2477-2488. [PMID: 22549046 DOI: 10.1016/s0140-6736(11)61849-7] [Cited by in Crossref: 678] [Cited by in F6Publishing: 710] [Article Influence: 61.6] [Reference Citation Analysis]
452 Kuo VC. Hepatitis E infection. Proc (Bayl Univ Med Cent) 2012;25:119-20. [PMID: 22481839 DOI: 10.1080/08998280.2012.11928804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
453 Yiu V, Gao R, Mulroy S. Hepatitis in a renal transplant patient--beyond the usual. Clinical Kidney Journal 2012;5:170-172. [DOI: 10.1093/ckj/sfs012] [Reference Citation Analysis]
454 Abravanel F, Mansuy JM, Huynh A, Kamar N, Alric L, Peron JM, Récher C, Izopet J. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol. 2012;54:152-155. [PMID: 22425538 DOI: 10.1016/j.jcv.2012.02.015] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
455 Shukla P, Nguyen HT, Faulk K, Mather K, Torian U, Engle RE, Emerson SU. Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J Virol 2012;86:5697-707. [PMID: 22398290 DOI: 10.1128/JVI.00146-12] [Cited by in Crossref: 182] [Cited by in F6Publishing: 186] [Article Influence: 16.5] [Reference Citation Analysis]
456 Rodríguez-Frias F, Jardi R, Buti M. [Hepatitis E: molecular virology, epidemiology and pathogenesis]. Enferm Infecc Microbiol Clin 2012;30:624-34. [PMID: 22386306 DOI: 10.1016/j.eimc.2012.01.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
457 Suneetha PV, Pischke S, Schlaphoff V, Grabowski J, Fytili P, Gronert A, Bremer B, Markova A, Jaroszewicz J, Bara C, Manns MP, Cornberg M, Wedemeyer H. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 2012;55:695-708. [PMID: 22006345 DOI: 10.1002/hep.24738] [Cited by in Crossref: 134] [Cited by in F6Publishing: 123] [Article Influence: 12.2] [Reference Citation Analysis]
458 Maylin S, Stephan R, Molina JM, Peraldi MN, Scieux C, Nicand E, Simon F, Delaugerre C. Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised. J Clin Virol. 2012;53:346-349. [PMID: 22293627 DOI: 10.1016/j.jcv.2012.01.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
459 Geng YS, Zhou Y, Wang YC. Progress in research of chronic hepatitis E. Shijie Huaren Xiaohua Zazhi 2012; 20(2): 125-130 [DOI: 10.11569/wcjd.v20.i2.125] [Reference Citation Analysis]
460 Koenecke C, Pischke S, Heim A, Raggub L, Bremer B, Raupach R, Buchholz S, Schulz T, Manns M, Ganser A, Wedemeyer H. Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country? Transplant Infectious Disease 2012;14:103-6. [DOI: 10.1111/j.1399-3062.2011.00702.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
461 Motte A, Roquelaure B, Galambrun C, Bernard F, Zandotti C, Colson P. Hepatitis E in three immunocompromized children in southeastern France. J Clin Virol 2012;53:162-6. [PMID: 22177988 DOI: 10.1016/j.jcv.2011.11.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
462 Jagjit Singh GK, Ijaz S, Rockwood N, Farnworth SP, Devitt E, Atkins M, Tedder R, Nelson M. Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV. J Infect. 2013;66:103-106. [PMID: 22166370 DOI: 10.1016/j.jinf.2011.11.027] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 5.1] [Reference Citation Analysis]
463 Razonable RR. Rare, unusual, and less common virus infections after organ transplantation. Current Opinion in Organ Transplantation 2011;16:580-7. [DOI: 10.1097/mot.0b013e32834cdaf2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
464 Nguyen HT, Torian U, Faulk K, Mather K, Engle RE, Thompson E, Bonkovsky HL, Emerson SU. A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture. J Gen Virol 2012;93:526-30. [PMID: 22113007 DOI: 10.1099/vir.0.037259-0] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 5.4] [Reference Citation Analysis]
465 Kamar N. Hepatitis e virus infection in Iranian kidney-transplant patients. Hepat Mon 2011;11:927-8. [PMID: 22308159 DOI: 10.5812/kowsar.1735143x.791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
466 Halleux D, Kanaan N, Kabamba B, Thomas I, Hassoun Z. Hepatitis E virus: an underdiagnosed cause of chronic hepatitis in renal transplant recipients. Transplant Infectious Disease 2012;14:99-102. [DOI: 10.1111/j.1399-3062.2011.00677.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
467 Hosseini Moghaddam SM. Hepatitis E virus and renal transplantation. Hepat Mon 2011;11:599-600. [PMID: 22140382 DOI: 10.5812/kowsar.1735143x.770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
468 Kamili S. Toward the development of a hepatitis E vaccine. Virus Res. 2011;161:93-100. [PMID: 21620908 DOI: 10.1016/j.virusres.2011.05.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]